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DNA harbors the genetic information in all living organisms and plays a pivotal role in passing 
the genetic information to the next generation. All living cells are exposed to numerous exogenous 
and endogenous agents that damage the DNA to form different lesions or adducts in DNA. 
Fortuitously, diverse DNA repair mechanisms exist in the living cells, which repair these DNA 
adducts before the replication apparatus of the cell copies the DNA. However, frequently extensive 
DNA damage or slow repair may allow replication bypass of a DNA lesion. As a result, cells adapt 
a DNA damage tolerance mechanism, termed as translesion synthesis (TLS) to bypass the lesions 
in DNA. Often, the TLS polymerases are of low fidelity and result in the misincorporation of the 
nucleobases generating mutations. If these mutations persist in the DNA, it may lead to alteration 
of genetic code and protein expression, thereby resulting in various diseases including cancer. 
In this thesis, I investigated the mutagenicity and genotoxicity of three different adducts including 
a bulky DNA-peptide cross-link, a tandem lesion containing 2-deoxyribonolactone with thymine 
glycol and oxidative stress induced formamidopyrimidine dG (Fapy.dG) in human embryonic 
kidney (HEK293T) cells. My goal is to investigate the role of each of the TLS polymerases (pol 
𝝶, pol 𝝹, pol 𝝸, pol 𝝵), by replicating these lesions in selective polymerase-deficient human cell 
lines and determine the types and frequencies of mutations. From these analyses, it was discovered 
Spandana Naldiga, University of Connecticut, 2020 
that these adducts are bypassed by TLS mechanism in both error-prone and error-free manner by 
the action of the specific TLS polymerases. From these studies, it was evident that the replicative 
bypass depends of the structure, DNA sequence context, and the orientation of the lesion in DNA. 
This research provides an insight to better understand the mutagenicity and toxicity of these lesions 







Replicative Bypass of a DNA-peptide Cross-link and Oxidative Single and 












submitted in partial fulfillment of the 
requirements for the degree of 
Doctor of Philosophy 
at the 
































































Doctor of Philosophy Dissertation 
 
 
Replicative Bypass of a DNA-peptide Cross-link and Oxidative Single and 









Major Advisor  





Associate Advisor  





Associate Advisor  


































































I would like to thank my academic advisor, Dr. Ashis Basu for his immense support and motivation 
throughout my PhD. I want to express my deepest gratitude for giving me freedom to work on my projects 
and valuing my perspective on the research. Working under his guidance has made me a strong and 
confident researcher. I want to thank my advisory commitee, Dr. Jing Zhao, Dr. Mark Peczuh, Dr. Steven 
Suib and Dr. Fatma Selampinar for their support and encouragement throughout my graduate career. My 
sincere thanks to the collaborators Dr. Natalia Tretyakova, Dr. Shaofei Ji, Jenna Thomforde at University 
of Minnesota and Dr. Marc Greenberg, Haidong Huang at Johns Hopkins University for providing us the 
DNA adducts to characterize and kinetic experimental data in support to our research findings. I thank the 
Department of Chemistry and Graduate school at University of Connecticut for giving me an opportunity 
to pursue PhD and for poster award and travel fellowships during my graduate career. My special thanks to 
the Charlene Fuller and Xiaoyang Liu for their assistance in the order requisitions for the research. I also 
thank Dr. Wu He and Dr. Bo Reese for their help in the instrument training and troubleshooting. I thank 
my mentors Dr. Paritosh Pande and Dr. Arindom Bose for the training in the lab techniques during my 
initial years of PhD. I thank all the lab mates for making research work in the lab less stressful and more 
fun. I thank my colleagues Dr. Arindom Chatterjee, Dr. Brent Powell and undergraduates Mishil Nana and 
Ryan Donnehy for their support. My special thanks to graduate student, Henric Bacurio and undergraduate 
Emily Janeiro for their assistance in project completion.  
I sincerely thank my dad, Venu Gopala Chary and mom, Padmasree for always believing in me in every 
step. My dad gave me the confidence to stand independent and the freedom to be whatever I want. I simply 
wouldn’t be what I am today and what I will be in the future. It is not without the encouragement and 
support of my husband and my best friend, Sravan who has been a constant companion both in my career 
and life. Thank for being my rock support in everything. I thank my sisters Snehitha and Samatha for their 
memories, support and love. I thank my mother and father in-laws, Vijayalaxmi and Rajeshwar Rao for 
their support and encouragement. I thank my grandmothers, aunts, brothers, cousins, nephews and nieces 
 vi 
for their love. Special thanks to my oldest friends, Bramhini, Vidya and Spandana for their support. Thanks 
to all my friends Jyoti, Saketh, Xudong, Di, Divya, Santosh, Spundana, Karteek for all the support and for 











































Table of Contents 
Chapter 1: Introduction……………………………………….……………………………….1 
                   Literature Survey…………………………………………………………………..3 
1.1 DNA damage…………………………………………………………………………………3 
1.1.1. DNA-protein cross-links (DPC) ……………………………………………………..4 
1.1.2 Abasic sites…………………………………………………………………………...6 
1.1.3 ROS………………………………………………………………………………….. 8 
1.2 DNA repair…………………………………………………………………………………..10 
1.2.1 Direct repair………………………………………………………………………….11 
1.2.2 Base excision repair………………………………………………………………….11 
1.2.3 Nucleotide excision repair…………………………………………………………...12 
1.2.4 Mismatch repair……………………………………………………………………...13 
1.2.5 Homologous recombination and Non-homologous end joining……………………. 14 
1.3 Translesion synthesis………………………………………………………………………...15 
1.4 TLS polymerases…………………………………………………………………………….16 
1.4.1 Polymerase 𝝶…………………………………………………………………………..16 
      1.4.2 Polymerase 𝝸…………………………………………………………………………...17 
      1.4.3 Polymerase 𝝹…………………………………………………………………………..18 
      1.4.4 Polymerase Rev1………………………………………………………………………18 
      1.4.5 Polymerase 𝜻…………………………………………………………………………...19 
1.5 Overview of Dissertation……………………………………………………………………..20 
1.6 References……………………………………………………………………………………23 
Chapter 2: Materials and Methods……………………………………………………………38 
 viii 
2.1 Materials……………………………………………………………………………………38 
      2.1.1 Enzymes………………………………………………………………………………38 
      2.1.2 Chemicals……………………………………………………………………………..38 
      2.1.3 Reagents and cells…………………………………………………………………….39 
2.2 Methods……………………………………………………………………………………..40 
      2.2.1 Purification of oligonucleotides using polyacrylamide gel electrophoresis…………..40  
      2.2.2 Plasmid quantification using agarose gel electrophoresis…………………………….40 
      2.2.3 Preparation of single stranded pMS2 plasmid………………………………………...41 
      2.2.4 Construction of modified pMS2 vector with site specific incorporation of adducts….43 
      2.2.5 Transfection of recombinant vector in human cells…………………………………..44 
      2.2.6 Translesion synthesis polymerase knockdown using siRNA transfection in human  
               cells…………………………………………………………………………………...44 
      2.2.7 Construction of TLS polymerase knockout cell lines………………………………...45 
      2.2.8 Total RNA isolation and quantification………………………………………………46 
      2.2.9 Reverse transcription – Polymerase chain reaction (RT-PCR) analysis……………...46 
      2.2.10 Real-time quantitative RT-PCR……………………………………………………..48 
      2.2.11 Western blot analysis………………………………………………………………..48 
      2.2.12 Double stranded DNA extraction from HEK293T cells…………………………….49 
      2.2.13 Electroporation of double stranded DNA (dsDNA) ………………………………..49 
      2.2.14 Replication and fixation of double stranded DNA onto Whatman filters…………..49 
      2.2.15 Mutational screening by Southern blot hybridization……………………………….50 
2.2.16 TLS efficiency……………………………………………………………………....53 
2.2.17 Primer extension assay using human replicative polymerases……………………..53 
 ix 
2.2.18 Single nucleotide incorporation assay……………………………………………….54 
2.3 References…………………………………………………………………………………...55 
Chapter 3: Error-prone replication of a 5-formylcytosine-mediated DNA peptide cross-link             
                    in human cells…………………………………………………………..................56 
3.1 Introduction………………………………………………………………………………….57 
3.2 Synthesis of DNA peptide cross-link (DpC) ………………………………………………..60 
3.3 Results……………………………………………………………………………………….61 
     3.3.1 Replication of DNA peptide cross-link in human cells………………………………...61 
     3.3.2 Complete mutation profile induced by DpC and role of TLS polymerases……………62 
3.3.4 TLS efficiency………………………………………………………………………..65 
     3.3.4 In vitro replication of a DpC lesion by replicative DNA polymerases 𝝳 and 𝝴 using  
             primer extension assay…………………………………………………………………67 
     3.3.5 Fidelity of replication of a DpC lesion by replicative DNA polymerases 𝝴 and 𝝳 by  




Chapter 4: Mutagenic effects of a 2-deoxyribonolactone-thymine glycol tandem DNA lesion 
in human cells………….………………………………………………………….....................81 
4.1 Introduction………………………………………………………………………………….82 
      4.1.1 Formation of thymine glycol (Tg) …………………………………………………….82 
      4.1.2 Formation of 2-deoxyribonolactone (L) ………………………………………………83 
      4.1.3 Formation of tandem lesion (LTg) ……………………………………………………84 
 x 
4.2 Synthesis strategies………………………………………………………………………… 86 
      4.2.1 Synthesis of oligonucleotides containing Tg………………………………………….86 
      4.2.2 Synthesis of oligonucleotides containing L and LTg………………………………….87 
      4.2.3 Modified pMS2 vector preparation with site specific incorporation of Tg, L, LTg…..88 
      4.2.4 Replication of isolated-Tg, isolated-L and tandem-LTg………………………………89 
4.3 Results……………………………………………………………………………………….90 
1) Isolated thymine glycol (Tg) …………………………………………………………………90 
       4.3.1 Complete mutation profile of isolated lesion Tg, when replicated in HEK 293T cells  
                and TLS polymerase knockout cells………………………………………………….90 
       4.3.2 Targeted point mutations at isolated-Tg lesion, replicated in HEK 293T cells and TLS  
                polymerase knockout cells……………………………………………………………91 
       4.3.3 Role of TLS polymerases in the bypass of Tg………………………………………..92  
 2) Isolated 2-deoxyribonolactone (L) …………………………………………………………..93 
       4.3.4 Complete base incorporation profile opposite isolated-L lesion, when replicated in  
                HEK 293T cells and TLS polymerase knockout cells………………….……………..93 
       4.3.5 Targeted base incorporation opposite isolated-L, replicated in HEK 293T cells and 
                TLS polymerase knockout cells……………………………………………………….94  
       4.3.6 Role of TLS polymerases in the bypass of 5'-TL………………………………………95 
       4.3.7 Sequence-dependent bypass of L (5'-TL and 5'-CL) ………………………………….96 
3) Tandem lesion (5'-LTg-3')………………………………………………………………….....98 
       4.3.8 Complete base incorporation profile of tandem lesion, 5'-LTg-3', when replicated in  
                HEK 293T cells and TLS polymerase knockout cells…………………………………98 
      4.3.9 Base incorporation opposite 5'-Targeted (L) component as part of tandem lesion, in HEK  
 xi 
               293T cells and TLS polymerase knockout cells……………………………………….99 
      4.3.10 Mutation profile of 3'-Targeted (Tg) component as part of tandem lesion in HEK 293T 
                 cells and TLS polymerase knockout cells……………………………………………100 
       4.3.11 Role of TLS polymerases in the bypass of tandem lesion, LTg…………………….102 




Chapter 5: Translesion synthesis bypass of Fapy.dG lesion (N-2, 6-diamino-4- hydroxy-5-  
                   formamidopyrimidine) in human cells…………………………..........................116 
5.1 Introduction…………………………………………………………………………………117 
5.2 Repair……………………………………………………………………………………….121 
5.3 Fapy.dG adduct……………………………………………………………………………..122 
5.4 Results………………………………………………………………………………………123 
       5.4.1 Replication of Fapy.dG in human cells………………………………………………123 
       5.4.2 TLS efficiency………………………………………………………………………..124 
       5.4.3 Complete mutation profile of Fapy.dG in HEK 293T and polymerase-deficient  
                cells…………………………………………………………………………………..125 
       5.4.4 Mutation frequencies of targeted point mutations at Fapy.dG lesion site, when 





List of Figures 
 
Figure 1.1 DNA peptide cross-link with lysine of peptide covalently linked to cytosine of DNA…6 
Figure 1.2 (A) 2-deoxyribonolactone as tandem lesion with thymine glycol (LTg) and (B) 2-
deoxyribonolactone as isolated lesion (L)…………………………………………………………7 
Figure 1.3 Structure of 2,6-diamino-4-hydroxy-5-formamidopyrimidine (FapydG)……………..9 
Figure 2.1 Single stranded pMS2 vector with ColE1, SV40, f1 origins of replication and MCS 
(multiple cloning site) containing restriction site…………………………………………………42 
Figure 2.2 Represents a typical image obtained post-hybridization by autoradiography. The 
signals represent the hybridization of corresponding probe to the adduct/control. The red arrows 
represent a typical mutant………………………………………………………………………...51 
Figure 3.1 Targeted and semi-targeted mutations induced in the progeny from the 5fC–linked DpC 
construct in HEK 293T (293T) and various polymerase KO or KD cells (as indicated). The data 
represent the mean and standard deviation (of total MF) from two to five independent experiments. 
The statistical significance of the difference in MFs between HEK 293T and TLS pol knockouts 
(KO) and/or knockdowns (KD) was calculated using two-tailed, unpaired Student’s t-test (*p < 
0.05; **p < 0.005)………………………………………………………………………………...63 
Figure 3.2 The types and frequencies of targeted mutations induced in the progeny from the 5fC-
linked DpC construct in HEK 293T cells and various polymerase KO or KD cells (as indicated). 
The data represent the mean and standard deviation (of the total targeted MF) from two to five 
independent experiments. The statistical significance of the difference in targeted MFs between 
HEK 293T and TLS pol knockouts and/or knockdowns (KD) was calculated using two-tailed, 
unpaired Student’s t test (*p <0.05; **p < 0.005)………………………………………………...64 
 xiii 
Figure 3.3 The extent of replicative bypass (or TLS efficiency) of 5fC-linked DpC in HEK 293T 
cells with or without various TLS polymerases. Percent TLS of the DpC construct in different 
polymerase knockout or knockdowns was measured relative to an internal control DNA. The data 
represent the mean and standard deviation of results from three independent experiments. HEK 
293T cells were treated with negative control siRNA (293T), whereas the other single or double 
polymerase knockouts (KO) or knockdowns (KD) are indicated below on the x-axis……………66 
Figure 3.4 Primer extension assays for replication bypass of 5fC-mediated DNA-peptide cross-
links by hpol 𝞮 hpol 𝞭 (A-D), the 32P-labeled 12-mer primer was annealed with a 23-mer template 
containing 5-formyl-dC (A and C) or the 11-mer peptide cross-link RPKPQQFFGLM (B and D). 
Polymerase reactions were initiated by addition of DNA polymerases and a mixture of dNTPs and 
quenched at selected time points prior to loading onto 20 % denaturing PAGE………………….68 
Figure 3.5 Single-nucleotide insertion opposite 5fC (control) and the 5fC-11-mer peptide cross-
links by hpol 𝞮. Template-primer complexes were incubated with hpol 𝞮 in the presence of 
individual dNTP and then quenched at preselected time points. X-5 -formylcytosine conjugate to 
RPKPQQFFGLM………………………………………………………………………………..70 
Figure 3.6 Single-nucleotide insertion opposite 5fC (control) and the 5fC-11mer peptide cross- 
link by hpol 𝞭. Template-primer complexes were incubated with hpol 𝞭 in the presence of 
individual dNTP and then quenched at pre-selected time points. X–5-formylcytosine conjugate to 
RPKPQQFFGLM………………………………………………………………………………..70 
Figure 4.1 (5R, 6S) isomer of Tg-adduct in the sequence 5'- GAAGACCTTgGGCGTCC -3'….86 
Figure 4.2 Total mutation profile of isolated-Tg lesion, when replicated in HEK 293T cells and 
polymerase knockdown (KD)/knockout (KO) cells. Data obtained from two/three independent 
experiments. * (p < 0.05); ** (p < 0.005)…………………………………………………………90 
 xiv 
Figure 4.3 Targeted point mutations at isolated-Tg site, when replicated in HEK 293T and TLS 
polymerase knockout (KO)/knockdown (KD) cells. Data obtained from two/three independent 
experiments. * (p < 0.05); ** (p < 0.005)…………………………………..……………………..92 
Figure 4.4 Percentage progeny recovered including base incorporation (full length products) 
opposite isolated-L and targeted deletions, when replicated in HEK 293T and polymerase 
knockout (KO)/ knockdown (KD) cells. Data obtained from two/three independent experiments. 
* (p < 0.05); ** (p < 0.005)……………………………………………………………………….93 
Figure 4.5 Targeted base incorporation opposite isolated-L, when replicated in HEK 293T and 
polymerase knockout (KO)/knockdown (KD) cells. Data obtained from two/three independent 
experiments. * (p < 0.05); ** (p < 0.005)…………………………………………………………95 
Figure 4.6 Percentage progeny recovered corresponding to 5'-TL and 5'-CL, including base 
incorporations (full length product) opposite isolated-L and deletions, when replicated in HEK 
293T cells. Data obtained from two/ three independent experiments…………………………….96 
Figure 4.7 Targeted base incorporation opposite L, when 5'-TL and 3'-CL were replicated in HEK 
293T cells. Data obtained from two/three independent experiments…………………………….97 
Figure 4.8 Percentage of progeny recovered corresponding to tandem lesion 5'-LTg-3', including 
base incorporation (full length product) opposite ‘L’ and deletions (1b and 2b), when replicated in 
HEK 293T and polymerase knockout cells. Data obtained from two/three independent 
experiments. * (p < 0.05); ** (p < 0.005)…………………………………………………………98 
Figure 4.9 Base incorporation opposite 5'-targeted (L) site as part of LTg, when replicated in HEK 
293T and polymerase knockout cells. Data obtained from two/three independent experiments. * (p 
< 0.05); ** (p < 0.005)……………………………………………………………………………99 
 xv 
Figure 4.10 Mutation profile of 3'- Targeted (Tg) component as part of LTg, when replicated in 
HEK 293T and polymerase knockout (KO) cells. Data obtained from two/three independent 
experiments. * (p < 0.05); ** (p < 0.005)………………………………………………………..100 
Figure 4.11 3' Targeted (Tg) point mutations when 5'-LTg-3' was replicated in HEK 293T and 
TLS polymerase knockout (KO) cells. Data obtained from two/three independent experiments.       
* (p < 0.05); ** (p < 0.005)………………………………………………………………...........101 
Figure 4.12 TLS efficiencies of Tg, LTg and L in HEK 293T and polymerase knockout (KO) 
cells. Data obtained from two/three independent experiments. * (p < 0.05); ** (p < 0.005)…...102 
Figure 4.13 TLS efficiencies of 5'-TL and 5'-CL in HEK 293T cells. Data obtained from two/three 
independent experiments………………………………………………………………………..104 
Figure 5.1 The two anomeric forms- 𝝰 and 𝝱 of Fapy.dG adduct in the DNA………………….120 
Figure 5.2 Structure of 𝝱-anomer of Fapy.dG lesion………………………………………..….122 
Figure 5.3 TLS efficiency of Fapy.dG in HEK 293T cells along with four single polymerase 
knockout cells. Results obtained from three individual experiments………………………..….124 
Figure 5.4 Mutation frequencies correspond to targeted and off-targeted mutations, when Fapy.dG 
was replicated in HEK 293T cells and single polymerase-knockout cells. Data represent three 
independent experiments…………………………………………………………………….….125 
Figure 5.5 Targeted point mutations at Fapy.dG site, when replicated in HEK 293T and 










List of Schemes 
 
 
Scheme 2.1 Protocol for the construction of recombinant vector with the oligonucleotide insert 
(adduct and control)………………………………………………………………………………43 
Scheme 2.2 Represents the siRNA induced knockdown of TLS polymerases and transfection of 
recombinant vector in HEK 293T cells. Followed by transformation of harvested DNA in E.coli 
competent cells…………………………………………………………………………………...45 
Scheme 2.3 Protocol for performing mutational screening by Southern blot hybridization followed 
by DNA sequencing analysis……………………………………………………………………..51 
Scheme 3.1 Methylation and oxidation of cytosine by DNMT transferases and TET-family 
dioxygenases respectively to form 5-formylcytosine………………………………………….....59 
Scheme 3.2 Preparation of 5fC-conjugated DNA peptide cross-link by forming Schiff base with 
5fC and Lysine of the peptide and stabilized by reduction………………………………………61 
Scheme 3.3 Recombinant pMS2 vector construction with 23-mer DNA peptide cross-link adduct 
followed by mutational screening using Southern blot hybridization and confirmed by DNA 
sequencing………………………………………………………………………………………..62 
Scheme 4.1 Oxidation of thymine to form thymine glycol (Tg) isomers (5R, 6S) and (5S, 6R)..83 
Scheme 4.2 Formation of tandem lesion (LTg), an oxidized abasic site resulted from the attack of 
OH• radical on thymine, under aerobic conditions……………………………………………….85 
Scheme 4.3 Formation of 2-deoxyribonolactone (L) from photochemical precursor, exposed to 
UV radiation at 350 nm. The precursor was incorporated in the oligonucleotide sequences shown. 
5'-GAAGACCTL*GGCGTCC-3'; 5'-GAAGACCL*TgGGCGTCC-3'…………………………87 
 xvii 
Scheme 5.1 Formation of 8-oxo.dG and Fapy.dG from oxidation of deoxyguanine by a hydroxyl 
radical. The N7 radical intermediate formed undergo either one electron oxidation to form 8-










































List of Tables 
 
 
Table 2.1 Represents the specific siRNA sequences designed and used in the single/double/ triple 
knockdown of TLS polymerases…………………………………………………………………45 
Table 2.2 Primers used for RT-PCR quantification of siRNA knockdown of TLS polymerases…47 
Table 2.3 Sequences of probes designed specifically for an adduct/control (eg. Fapy.dG) for 
Southern blot hybridization with melting temperature at 49 ºC. A reverse primer designed for 
sequencing process of DNA extracted from mutant cultures…………………………………….52 
Table 2.4 Represents the sequence of internal control used to calculate TLS efficiency and the 
corresponding IC probe designed for Southern blot hybridization……………………………….53 
Table 3.1 Steady-state kinetics parameters for single-nucleotide incorporation opposite 5fC or the 






CHAPTER – 1 
                                              INTRODUCTION 
 
Cancer is a multi-step process, triggered by the abnormal proliferation of cells. It is also the second 
leading cause of death worldwide. Most common types reported are lung, breast, colorectal, and 
prostate cancers (1). According to international agency for research on cancer (IARC) (2), 9.6 
million deaths were reported in 2018, with lung cancer being the leading cause in both men and 
women. As per IARC statistics (2), 11.6 % new cases reported were of lung and breast cancers, 
followed by 10.2 % of colorectal, 7.1 % of prostrate, 5.7  % of stomach cancers. Abnormal cellular 
proliferations are provoked by several factors such as, inheritance of genetic disorders, abnormal 
expression of transcription factors, formation of successive mutations in the genes including the 
tumor suppressor gene, p53. Different types of cancers are developed from several gene mutations, 
which are formed primarily from the replication of DNA damage (1,3). These mutations alter the 
gene expression in the cells and promote carcinogenesis. Carcinogenesis is a multi-step process 
which include initiation, promotion, and malignant progression (4). The initiating agent becomes 
a carcinogen when treated at higher or repeated dosages, initiate malignant progression. The 
promoting agent is a non-genotoxic agent but act synergistically with the initiator to promote the 
progression of cancer (4). Several carcinogenic agents such as chemical compounds from cigarette 
smoke, diesel exhaust, charred meat, physical agents such as radiation, microbial agents (bacteria, 
viruses) may result in the dysfunction and alteration of gene expression in the cells, lead to cancer 
and various other diseases. 
Other implications due to accumulation of gene mutations are premature aging or death of the 
cells. The somatic mutation theory of cancer proposes that (5, 6) the accumulation of non-lethal 
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mutations (driver mutations), when associated with mutant cell proliferation causes cancer.  
Effects of this association results in chromosomal aberrations, developmental disorders, rare 
genetic diseases etc. Fanconi anemia (FA) is a rare genetic disorder that occurs due to the mutations 
caused in 21genes, which have a role in repair of the inter and intra-strand cross-links (ICLs) in 
DNA (7, 8). The effects of FA include chromosomal instability and bone marrow failure. 
Accumulation of somatic mutations in the cells may also lead to developmental disorders and 
cancer such as melanoma. Epigenetic modifications such as DNA methylation, covalent histone 
modifications, non-coding RNAs such as miRNAs in the cells are essential for mammalian gene 
expression (9). However, any disruption will lead to the genetic alteration and cancer. For instance, 
hypomethylation and hypermethylation of DNA will alter the gene expression which are 
responsible for cell cycle control, repair and apoptosis (9). Hence it is extremely important to study 
the etiology of gene mutations caused by various DNA damages in order to explore the treatment 














1.1 DNA DAMAGE: 
DNA contains the genetic information, vital to the survival and propagation of all living organisms. 
Every human cell is exposed to various endogenous and exogenous agents that damage the DNA; 
it is estimated that about 70000 lesions form per day (3,10). These DNA damages may occur 
spontaneously or due to the prolong exposure to various chemical and environmental agents. It is 
estimated the about 105 spontaneous DNA lesions are formed per day (10). If left unrepaired, the 
lesions undergo low fidelity replication which generate gene mutations, thereby leads to tumor 
progression (4).  
Endogenous DNA damage in the cells include reactive metabolites like reactive oxygen species 
(ROS), reactive nitrogen species (RNS) produced as a result of oxidative stress. ROS includes 
hydroxyl radical (OH•), superoxide (O2•-) and hydrogen peroxide (H2O2). The highly reactive 
hydroxyl radicals (OH•) form tandem lesions, formamidopyrimidines, strand breaks, and various 
purine/pyrimidine modifications (11-13). Other endogenous processes such as deamination 
reactions induce conversion of cytosine to uracil and SAM-induced methylation forms 3-
methyladenine (3meA) and 7-methylguanaine (7meG) (3). Some of these processes may occur 
spontaneously as in the case of depurination/depyrimidination resulting in abasic sites (12). 
Exogenous DNA damage include exposure of DNA to many environmental agents. These 
environmental sources can be either physical or chemical agents (3). Physical agents include UV 
and ionizing radiation (IR). UV induces the formation of cyclobutane pyrimidine dimers (CPDs), 
6-4 photoproducts (PPs) (11). X- rays induce oxidation of the nucleobases, formation of single 
strand breaks (SSBs) and double strand breaks (DSBs) (14). Chemical agents induce the formation 
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of various bulky and non-bulky DNA adducts in the cells, which may disturb the architecture of 
the DNA helix. These alterations may influence the replication process to generate mutations. 
Some of these are mentioned here and studied in this thesis.  Simple alkylating agents such as 
methylmethanesulfonate (MMS) and temozolomide form N3-methyladenine, anti-cancer drugs 
such as mitomycin C (MMC), cisplatin, cyclophosphamide and nitrogen mustard induce inter-
strand cross-links (ICLs) (3). Topoisomerase inhibitors such as camptothecin (CPT), etopsin, 
formaldehyde induce SSBs or DSBs and DNA protein cross-links (DPCs) (3,15). The chemical 
compounds in cigarette smoke (nitrosamines, NNK, NNN) (16), diesel exhaust (3-
nitrobenzanthrone, 1-Nitropyrene) (17, 18), coal tar (polycyclic aromatic hydrocarbons (PAHs)) 
(19), dyes, industrial chemicals in the preparation of PVC (vinyl chloride, 1, 3-butadiene) (20),  
aflatoxins (food contaminants) (21), charred meat (aromatic amine IQ) (22) metabolize in the cells 
to produce bulky DNA adducts and promote tumorigenesis.  
 
1.1.1 DNA protein cross-links (DPC): 
DNA protein cross-links are a class of bulky DNA adducts formed when the nucleobase of DNA 
covalently bonds with an amino acid moiety of a protein or peptide (23, 24). Due to their bulky 
size and helix-distorting property, DPCs disrupt the replication and transcription process which 
may be fatal to the cells. DPCs are induced by various sources categorized as environmental, 
therapeutic, and endogenous (24). DPCs formed by various agents are chemically distinct and also 
depend on the cell cycle phase, cellular metabolism, and temperature. Environmental sources 
include UV light, IR (ROS, RNS), metal ions like chromium, nickel, carcinogens like diepoxy 
butane, acrolein, crotonaldehyde, 1,3-butadiene (25-29). Therapeutic sources include the anti-
cancer drugs like cisplatin and nitrogen mustard (23, 30-33).  
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Endogenous sources may also result in either non-enzymatic or enzymatic DPC formation (24). 
Non-enzymatic pathways include a majority of reactive aldehydes such as formaldehyde and 
acetaldehyde, which form DPC.  DPCs may also form as intermediates in the processes such as 
amino acid metabolism, oxidative demethylation (25, 34). Most extensively studied DPCs are 
formaldehyde-induced adducts (FA-DPC). It is reported that some FA-DPCs are reversible and 
may involve a broad variety of proteins (35, 36). These FA-DPCs are previously studied in vitro 
(37), and also in S. cerevisiae (38) and human cells (39). Other non-enzymatic sources include the 
formation of DPC through abasic sites. These abasic sites contain reactive aldehyde groups, which 
when react with the proteins and smaller peptides, form DPC and DNA peptide cross-links (DpCs) 
(27, 37, 40).  
Enzymatic sources include topoisomerases, DNA glycosylases, MGMT, PARP-1 enzymes, which 
form transient complexes with the DNA as part of its mechanism but in certain conditions they 
can get trapped onto the DNA to form DPCs (41-43). DNA glycosylases and PARP-1 enzymes 
are involved in the formation of abasic sites as part of base excision repair (BER) mechanism, but 
these sites are prone to covalent cross-linking with the enzymes itself to form DPC especially by 
short-patch BER (44, 45). Studies have been conducted both in vitro (15) and in vivo (39) to 
explore the mutagenicity and cytotoxicity of DPCs as well as DpCs, by generating synthetic site-
specific DNA cross-link adducts. DPCs can also be repaired by nucleotide excision repair (NER), 













FIGURE 1.1: DNA peptide cross-link with lysine of peptide covalently linked to cytosine of DNA 
 
1.1.2 Abasic sites: 
Apurinic/apyrimidinic (AP) sites in the DNA are referred to as abasic sites. AP sites can be 
generated due to spontaneous loss of a base, by alkylating agents or by the DNA N-glycosylases, 
which remove the modified base at the damage site, as a step in BER process. The rate of 
depurination is higher than depyrimidination of DNA in the cells (47). AP sites are formed by 
spontaneous hydrolysis of the glycosidic bond between the deoxyribose sugar and the nucleobase 
along with the disruption of the phosphodiester bond with the neighboring nucleobases in the DNA 
(48). It is reported that about 10000-50000 abasic sites are produced in the mammalian cells per 
day under aerobic conditions (49, 50). Replication of these abasic sites may result in ICLs, DSBs 
and histone modification (51-53). These abasic sites are highly electrophilic and chemically 
unstable. Oxidized AP sites react with the DNA repair enzymes and inhibit their function. They 
are also reported as highly mutagenic and generate single base-pair substitutions in E.coli (54).  
Oxidized abasic sites are produced by ROS, when exposed to higher levels of IR or prone to 
oxidative stress (55). These sites also generate DPCs by covalently cross-linking to the different 
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enzymes and block the replication and transcription process. One such important oxidative abasic 
lesion is the formation of 2-deoxyribonolactone (L). Formation of L also occurs when DNA is 
exposed to Cu (OP)2 and antitumor agents such as Neocarzinostatin chromophore (NCS) (56, 57). 
The absence of the nucleobase exposes the C1'-H bond of the deoxyribose backbone which is 
prone to the oxidation and under aerobic conditions, produce L (58, 59). Abasic sites are repaired 
mainly by BER and to some extent by NER when the former repair process is disrupted (60, 61). 
L is generated as an isolated lesion as well as a part of tandem lesion by the attack at C1'-H bond 







      
A.            B. 
 
FIGURE 1.2: (A) 2-deoxyribonolactone as tandem lesion with thymine glycol (LTg) and (B) 2-










Reactive oxygen species (ROS), its corresponding radicals and non-radicals are generated as 
byproducts in the aerobic metabolism (64, 65). Low levels of ROS are beneficial to the living 
organisms as they act as signaling molecules in regulating the biological and physiological 
processes like cell cycle progression. High levels of ROS will react with biomolecules such as 
lipids, proteins, and DNA, causing damage. ROS includes superoxide anion (O2•-), hydrogen 
peroxide (H2O2) and highly reactive hydroxyl (OH•) radicals (11, 12, 66, 67). Different ROS react 
with the nucleobases (dA, dT, dG, dC) to form various DNA lesions (68). Of the four bases, ROS 
reacts with dA and dG to a greater extent (67). The oxidatively damaged DNA is efficiently 
repaired by BER (61, 69).  
Free radicals like OH• react with nucleobases by addition followed by abstraction pathway. The 
radicals attack the C5 and C6 position of pyrimidines (dT, dC) and add OH groups, thus generate 
free-radicals and further abstracts the hydrogen atom (12, 70, 71). These C5 and C6 free-radical 
containing intermediates under aerobic conditions will produce various lesions. The most notable 
lesions are thymine glycol, 5- formyluracil, 5- hydroxycytosine, 5- hydroxyuracil. For purines (dA, 
dG), the OH•  radicals attack C4, C5 and C6 positions to generate free-radicals (70). Under aerobic 
conditions, these radicals form various lesions such as 8-oxopurines (8-oxodG, 8-oxodA) and 
formamidopyrimidines (12, 67, 70). Extensive studies were performed to understand the 
replicative and repair processes of 8-oxopurines in E.coli (72) and human cells (73-75). The 
formamidopyrimidines are 2, 6-diamino-4-hydroxy-5-formamidopyrimidine (FapydG) and 4,6-
diamino-5-formamidopyrimidine (FapydA), of which the earlier lesion is more notable studied 
(76, 77). These OH•  radicals also form the tandem lesions, in the presence of O2 and the targeted 
base is 5' to the pyrimidine (78, 79). For instance, attack of thymine with OH• under aerobic 
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conditions will result in the formation of hydroperoxyl radical; this in turn attacks either dA to 
form the tandem lesion, 5'-2-deoxyribonolactone -thymine glycol -3' (5'-LTg-3') (62, 63).  
In this thesis, the implications of some of the DNA damages such as tandem lesion LTg, isolated 
lesions L and Tg, bulky DpC, ROS-induced FapydG was studied in human cells and are reported 





















1.2 DNA REPAIR: 
DNA damage occurs in all the living organisms and fortunately, to tackle these disruptions, DNA 
damage responses are activated in the cells. If these damages cannot be repaired the DNA may 
undergo replication by error-prone translesion synthesis (TLS) generating high frequency of 
mutations. Alternatively, if this damage blocks the cellular processes, the cell is subjected to 
apoptosis (61, 80-82).  
DNA damage responses in the cells include the following, 
• Removal of DNA damage by repair mechanisms 
• Activation of DNA checkpoint to arrest the cell cycle progression 
• Altering the transcription profile in order to modify the gene expression. 
• Programmed cell death (apoptosis) 
Different types of damages are recognized by various factors, which trigger the corresponding 
DNA repair mechanisms. These are categorized into four types: 
1.2.1 Direct repair 
1.2.2 Base excision repair 
1.2.3 Nucleotide excision repair 
1.2.4 Mismatch repair 







1.2.1 Direct Repair: 
Two mechanisms of direct repair include the enzymes photolyase and methylguanine DNA 
methyltransferase (MGMT) acting at the DNA damage site (61, 80). Photolyase repairs UV-
induced lesions cyclo-pyrimidine dimers (CPDs) and 6-4 photoproducts (6-4 PPs) by direct 
reversal (83). This repair mechanism does not occur in mammalian cells, in which instead the cells 
adapt NER to repair these lesions. MGMT removes the alkyl groups from the pyrimidines to 
convert into normal bases. This enzyme converts O6-methyl guanine into guanine by eliminating 
O6-methyl group (83). 
 
1.2.2 Base Excision Repair (BER): 
Spontaneous DNA damages which significantly doesn’t distort the double helix, are repaired by 
BER pathway (80). For example, the damages caused by deamination, alkylation and oxidation by 
various agents as discussed above (69). BER occurs both in nucleus and mitochondria of a living 
cell and it prevents the cells from aging, cancer, and neurodegeneration (69). BER pathways begin 
with the recognition of the damaged site by DNA glycosylases, which are lesion specific and 
removes the damaged base to form an abasic (AP) site (49). Based on the type of glycosylases 
recruited in the base excision step, the repair proceeds in two ways, one is short-patch BER (1-
base removal) and another is long-patch BER (2-10 bases removal) (60, 69, 84).  
 
A. Short-patch BER (69):  
In the first step, the AP site is created by action of N-glycosylases to remove the damaged base, 
followed by AP lyase, which cleaves the phosphodiester bond at 3' end of the AP site. Then, AP 
endonuclease1 (APE1) cleaves the 5' end of the phosphodiester bond to create a gap. Next, pol 𝝱 
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is recruited to insert a single nucleotide complementary to the template in the gap. Next, the gap 
is sealed by ligation using ligase- III/ XRCC1 complex.  
 
B. Long-patch BER (69,85): 
In this process, the AP site is formed by hydrolytic glycosylases followed by the cleavage of the 
phosphodiester bond at 5' end of the AP site by APE1 enzyme. Then proliferating cell nuclear 
antigen replication factor C (PCNA-RFC) complex recruit high fidelity replicative polymerases 
𝝳/𝝴 to carry out the insertion of new bases by displacing the existing ones. This 5'- displaced 
nucleotide stretch is cleaved by flap endonuclease-1 (FEN1) and the gap is sealed by ligation using 
ligase-I enzyme. 
 
1.2.3 Nucleotide Excision Repair (NER): 
Broad range of bulky or distorting adducts are repaired by NER such as bulky DPCs, UV-induced 
lesions (CPDs, 6-4 PPs), adducts from polycyclic aromatic hydrocarbons (PAHs), aromatic 
amines, oxidative induced cyclopurines, adducts formed from chemotherapeutic drugs like 
cisplatin, ICLs and so on (12, 46, 86). The lesions which are bulky and thermodynamically 
destabilize the DNA helix make very good substrates for NER. There are categorized into two 
types based on the platform where it occurs, namely transcription-coupled NER (TC-NER), which 
repairs the genes in the transcribed strand and global genome NER (GG-NER) (87), which repairs 
the genes at any stage of the cell cycle and location in the genome. Deficiencies in the NER repair 
proteins will lead to skin cancer related genetic disorders such as xeroderma pigmentosum (XP), 
Cockayne’s syndrome, trichothiodystrophy. In this repair process (88), the lesion containing strand 
is recognized by the protein complex XPC/ RAD23B, by binding to the non-damaged strand at the 
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site opposite to the lesion. The factor TFIIH interacts with the XPC-RAD23B and unwinds the 
DNA by its subunit XPB. The unwinding proceeds until its other subunit XPD encounters the 
lesion, then recruits XPA, RPA, XPG to form pre-incision complex. The first incision occurs at 5' 
end of the lesion by ERCC1-XPC complex with interacts with XPA of the pre-incision complex. 
Following this, synthesis of the repair strand occurs by recruitment of pol 𝝳/𝝹/𝝴, starting at the 
incised 5' end. Then, a 3' incision occurs corresponding on the strand by XPG, while the synthesis 
of the new strand continues. Thus, the repair strand synthesis aided by DNA polymerases pol 𝝳/𝝹/𝝴 
proceeds until the 3' end incision position and further the nick is sealed by ligation using DNA 
ligase I/III𝝰.  
 
1.2.4 Mismatch repair (MMR) (89): 
MMR is triggered to repair the misincorporation of nucleobases, insertions/deletions (indels) that 
happen during DNA replication and recombination in living cells. It is a highly conserved pathway 
in eukaryotes. The eukaryotic MMR pathway (90) is complicated, and the proteins recruited 
depends on the short and long indels present in the daughter strand synthesized after the process 
is completed. MMR is tightly associated with the DNA replication and is highly active during the 
S-phase of the cell cycle. Deficiency of the MMR repair proteins will result in persistence and 
replication of mutations and these will lead to gene expression alterations. It was reported that their 
deficiency leads to colon, endometrial, ovarian and stomach cancers in mammals.  
In this repair process (91, 92), the proteins MutS𝝰/MutS𝝱 recognizes the small (~3 nucleotides) 
and large (~13 nucleotides) base mismatches/indels. MutS proteins bind at the mismatch site by 
PCNA/RFC complex, then recruits MutL𝝰 protein, which is a heterodimer with MLH1 and PMS2 
subunits, to form a ternary complex. The endonuclease activity of the PMS2 is triggered to 
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translocate towards the 5' end of the mismatch and make a nick on the strand. Following this, 
EXO-I enzyme is recruited at the 5' nick and excises the nucleotides by progressing towards the 3' 
end, a few nucleotides past the mismatch site. The repair strand is then synthesized by recruiting 
pol 𝝳 at the 5' nick to proceed to 3' end. The gap at 3' end is then ligated by DNA ligase I.  
 
1.2.5 Homologous recombination (HR) and Non-homologous end joining (NHEJ) (93): 
DSBs in eukaryotes are repaired by two pathways, HR and NHEJ, where NHEJ is the dominant 
pathway. Failure to repair DSBs is fatal thereby leads to apoptosis and senescence of cells. Both 
pathways occur during the cell cycle, where HR occurs only during S and G2 phase of cell cycle 
and NHEJ occurs at G1 phase. Both of these pathways are important in the T-cell and B-cell 
development, immunoglobulin V(D)J combination. 
In this repair process (94, 95), the initial step is recognition of DSB and to bind Ku heterodimer 
(70/80) on the 5' and 3' sides of the break. Ku acts as a scaffold to recruit the necessary factors and 
enzymes for the repair process. These are DNA-PKs, XRCC4, XLF, APLF, DNA ligase IV to 
form a stable complex with existing Ku-DNA which covers the area of DSB. DNA-PKs, then auto 
phosphorylate and releases from the complex producing a nick. The nick is then sealed by DNA 
ligase IV present in the complex. Followed ligation, remaining factors are released upon the 
ubiquitination of Ku. There exists an alternative pathway for more complex DNA damage which 






1.3 TRANSLESION SYNTHESIS: 
As mentioned in the previous sections, the DNA damage in the cells is most definitely be repaired 
by the various DNA repair mechanisms. But few of the lesions are inefficiently repaired by the 
cell. An alternative mechanism is adapted by the cells in order to survive, termed as translesion 
synthesis (TLS) (96, 97). The specialized polymerases called TLS polymerases bind at the stalled 
replisome to traverse the DNA damage and continue with the replication process. These TLS 
polymerases are of low-fidelity, hence may incorporate wrong nucleobases opposite the damage 
site inducing mutations, thus resulting in the error-prone replicative bypass. Irrespective of this, 
the DNA damage-tolerance mechanism is important for the cell survival and development of 
altered traits in the organisms (81). On the other hand, it is primarily responsible for mutagenesis 
and carcinogenesis. TLS is conserved from prokaryotes such as  E. coli to mammals including  
humans (96).  
 
Mechanism (97, 98): 
TLS is triggered when the replisome encounters a damaged base and gets stalled. In normal 
replication process, PCNA along with PIP factor clamps/carries the high-fidelity replicative DNA 
polymerases 𝝳/𝝴 on lagging/leading strands respectively. At the stalled replisome, the polymerase 
switch from replicative to TLS polymerases is necessary. PCNA then gets ubiquitinated using 
proteins Rad 6 and Rad 18, which recruits TLS polymerase/s to incorporate a complementary base 
opposite the damaged site and further extends a few bases. After the bypass of the damaged site 
and further extension, the polymerase switch was reversed as a result of deubiquitylation of PCNA, 
and replicative DNA polymerases will continue the replication. This reversal is important to reduce 
the misincorporation of bases opposite undamaged bases in the DNA replication process as TLS 
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polymerases have low fidelity. However, it is due to their wider enzyme catalytic sites as oppose 
to pol 𝝳/𝝴, that they play an important role in the bypass of modified bases. 
 
1.4 TLS POLYMERASES: 
Five human TLS polymerases have been discovered, and they belong to Y-family (pol 𝝶, 𝝹, 𝝸, 
Rev1) and B-family (pol 𝝵) (99). TLS polymerases possess wider catalytic sites which can 
accommodate distorted and bulkier nucleobases, than the tight sites of replicative polymerases. 
However, they result in the misincorporation of bases due to lower fidelity, as they lack 3'->5' 
proofreading activity after the replication (96). Irrespective of regulated transcriptional processes, 
these polymerases may extend their replication beyond the damaged site and result in unwanted 
mutagenesis. TLS polymerases are conserved in evolution and the process occurs in E. coli, S. 
cerevisiae and H. sapiens. The different types of polymerases in humans and their roles are 
described below (100).  
 
1.4.1 Polymerase 𝝶: 
Polymerase 𝝶 belongs to Y-family and is translated from gene Rad 30A (in humans) and Rad 30 
(in yeast). It plays an important role in the bypass of the UV-induced lesions (CPDs and 6-4 PPs) 
(101). Pol 𝝶 possess broader active site which accommodate both dTs of CPD lesion and are 
bypassed in an error-free manner by incorporating dA complementary to it. The extension is also 
completed by pol 𝝶 beyond the lesion site up to 3 bases (102). This ability of pol 𝝶 to accommodate 
two bases facilitates the bypass of tandem lesions, such as ICLs at G-G sites formed by the 
therapeutic agent, cisplatin (103). In the bypass of 6-4 PPs, pol 𝝶 can only accurately bypass one 
of the bases and a second polymerase, pol 𝝵 is required to complete the bypass and further 
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extension (104-106). It is reported that pol 𝝶 also plays an important role in error-free bypass by 
incorporating dC, opposite the oxidative DNA damage, 8-oxo-dG and its extension is facilitated 
by pol 𝝵 (107, 108). Deficiency or mutation in pol 𝝶 sequence, results in the genetic disorder 
xeroderma pigmentosum variant (XP-V), due to which the individual is susceptible to the UV-
sunlight induced skin cancer (109). 
 
1.4.2 Polymerase 𝝸: 
Polymerase 𝝸 plays an important role in the bypass of oxidative DNA damages (110). It is 
translated from the gene Rad 30B in humans and is absent in yeast (111). A unique trait of pol 𝝸 is 
the replication may proceed both in error-free or error-prone manner. This nature of pol 𝝸 bypass 
is dependent on the conformation of the lesion in its unique active catalytic site. If a syn 
conformation is adapted, it will result in hoogsteen-base pairing with the incoming nucleobase 
(112). With the exception of 8-oxo-dG bypass, where the lesion adapts a syn conformation in the 
pol 𝝸 active site, it results in a Watson-Crick base pairing with the incoming dC base (110). There 
also exists an asymmetric fidelity between damaged bases, dA and dT, where pol 𝝸 incorporates 
dT (correct base) and dG (incorrect base) respectively during the TLS (113). Pol 𝝸 can also bypass 
some of the tandem lesions, when the damages are present in closer proximity to each other. Pol 𝝸 
and pol 𝝶 are reported to have a role in the bypass of CPDs in vivo, which is proved by the resulted 
accelerated UV-induced tumors in mice (114). In few cases, pol 𝝸 also participates in the short-
patch BER process replacing pol 𝝱 function, where pol 𝝸 possesses dRP lyase activity and interacts 
with the scaffold protein XRCC1 (115). Due to its error-prone nature, pol 𝝸 is also responsible for 
the occurrence of somatic hypermutations in the antibody genes in vivo (97). 
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1.4.3 Polymerase 𝝹: 
Polymerase 𝝹 plays an important role in the error-free bypass of the various bulky N2-dG-linked 
adducts and ICLs. Pol 𝝹 is conserved in bacteria and humans but not in yeast (100). The active 
catalytic site of pol 𝝹 is reported to possess an N-terminal extension (N-clasp) which can recognize 
the accommodation of bulky lesions in the minor groove of DNA (116).  It is also reported that 
the dinucleotide lesions block the pol 𝝹 bypass because, the active site of pol 𝝹 can fit only one 
Watson-Crick base pair (116). Pol 𝝹 aids in the extension of DNA past the damaged site with high 
fidelity, in association with other TLS polymerases like pol 𝝸, pol 𝜻 which participates in the lesion 
site bypass (117). For example (117), in cisplatin-ICL adduct (Pt-GG), in vitro primer extension 
studies proved that pol 𝝹 was unable to bypass the first encountered 3'-dG but can bypass the 
second 5'-dG. Hence, base incorporation opposite 3'-dG is aided by pol 𝝶 and then pol 𝝹 
incorporates dC opposite 5'-dG. Pol 𝝹 is also hypothesized to participate in the NER process, 
particularly associates with pol 𝝳 in the gap filling step after the excision step in NER. However, 
this association could lead to high mutation rate in the repaired strand (118).  
 
1.4.4 Polymerase Rev1: 
Rev1 polymerase is translated from gene Rev1 in both humans and yeast. Rev1 acts as both 
catalytic and non-catalytic forms in TLS mechanism (111). The catalytic role of Rev1 is to 
incorporate dC opposite limited types of dG adducts and abasic sites. TLS bypass by Rev1 
proceeds in a unique manner where the damaged base (dG) is displaced from the double helix and 
the incoming dC is paired with the Arg-324 moiety of Rev1 (119). Hence, the polymerase is also 
termed as template-independent dC transferase. It is also involved in the formation of DNA 
secondary structures, triplex repeats and G-quadruplexes (120).  
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The non-catalytic role of Rev1 polymerase is to coordinate interactions with PCNA, ubiquitin and 
other TLS polymerases (121). In yeast cell mutagenesis, Rev1 interacts with Rev3 subunit via 
Rev7, pol31, pol32 accessory subunits of pol 𝝵 to promote the error-prone extension bypass (122). 
In human cells, Rev1 acts as a scaffold at the stalled replication fork and recruit Y-family 
polymerases for the base incorporation step and pol 𝝵 for the extension step of TLS (111).  
 
1.4.5 Polymerase 𝝵: 
Polymerase 𝝵 plays a major role in the TLS and damage-induced mutagenesis in yeast and human 
cells. In humans, pol 𝝵 comprises of four subunits, catalytic Rev3, accessory subunits Rev7, polD2, 
polD3, hence may be represented as 𝝵 4 (97, 123). Rev3 is large subunit with > 3000 residues and 
is twice as the size of the yeast homolog Rev3p. Yeast also contains 𝝵 4 with Rev3-Rev7-pol31-
pol32 subunits (124). Rev3 is translated from Rev3L gene in humans. Rev7 is an important non-
catalytic subunit and links the Rev3 of pol 𝝵 to Rev1 polymerase which promotes the TLS 
replication bypass of damaged DNA (97). Mainly, it is reported that pol 𝝵 -Rev1 complex play an 
important in the DSB repair (97). Pol 𝝵 mainly involves in the error-prone lesion bypass as it lacks 
the proofreading exonuclease activity. Pol 𝝵 involves in the extension step of TLS, as it is 
inefficient in the base incorporation opposite the damaged base (108). For instance, it is reported 
(125) that in the TLS bypass of the cisplatin adduct, pol 𝝶 participates in the base incorporation 
and pol 𝝵 in the strand extension step, before the polymerase switch. It is reported from the human 
and mice cell studies that mutation in Rev3L gene resulted in the embryo lethality and growth 
defects (126). Hence, pol 𝝵 is important in the normal cell proliferation and development of 
embryos in mammals.   
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1.5 Overview of Dissertation: 
 
The goal of the dissertation was to investigate the replicative bypass of the damaged DNA adducts 
in human embryonic kidney (HEK 293T) cells. Three DNA adducts, bulky DNA-peptide cross-
link, a tandem lesion containing oxidative abasic site, 2-deoxyribonolactone and thymine glycol, 
oxidative stress induced formamidopyrimidines were studied. A site-specific approach was 
employed to understand the mutagenicity and cytotoxicity of these adducts in human cells. For 
this purpose, three single stranded recombinant vectors were constructed with these adducts and 
replicated in HEK 293T cells along with selective single/double/triple knockdown or knockout of 
TLS polymerases from the cells. These polymerase deficient cells were obtained either by siRNA-
induced gene silencing or CRISPR-Cas9 mediated gene editing techniques. Further, the mutational 
screening was achieved by performing Southern blot hybridization followed by DNA sequencing 
analysis. The biological implications of these adducts were studied independently in the 
subsequent chapters which were outlined below. 
 
Chapter 1 focusses on the introduction of various concepts that facilitates in the understanding of 
DNA damage and its replication in the cells. A broad overview of types of DNA damages and its 
various sources were discussed. Detailed review of DNA protein cross-links, abasic sites and 
oxidative stress induced DNA adducts was included. Unique DNA repair mechanisms which 
recognize and eliminate various adducts were described. Finally, the adducts which were immune 
to repair, were replicated by a DNA damage tolerance mechanism termed as translesion synthesis 
(TLS) was explained. Further, TLS is mediated by various polymerases, with adduct specific 
recognition criteria were also discussed.    
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Chapter 2 focusses on the materials and methods employed in the study. Various chemicals, 
enzymes and reagents used were mentioned. A detailed methodology of the techniques involved 
in the recombinant DNA technology, siRNA mediated transfection, in vitro primer extension, 
nucleotide incorporation assays were discussed. A comprehensive protocol description was 
included for the Southern blot and western blot hybridizations along with denaturing 
polyacrylamide and agarose gel electrophoresis. The sequences of probes and primers designed 
and employed in various procedures were reported. This explicit review of the techniques will 
enable the reader to understand the choice of these methods and its importance in the conclusions 
of the study.  
 
Chapter 3 focusses on the mutagenicity and cytotoxicity effects of epigenetic mark, 5-
formylcytosine mediated DNA peptide cross-links (DpC) in human cells. A detailed explanation 
of the formation and synthesis of adduct was included. From the calculated mutation frequencies, 
it was revealed that the predominant targeted site mutations were C->T and C-deletions. From the 
TLS efficiencies obtained, it was evident that the predominant bypass of DpC is through TLS in 
an error-prone manner. However, from the in vitro primer extension assays, it was observed that 
replicative polymerases were as well able to bypass the damage in an error-free manner, albeit 
very slowly.  
 
Chapter 4 focusses on the compare and contrast study of a tandem lesion with that of its 
corresponding isolated lesions, in terms of its TLS efficiencies, nucleotide incorporations and 
deletions during replication. The tandem lesion (LTg) studied include oxidized abasic site 2-
deoxyribonolactone (L), positioned 5' to thymine glycol (Tg) and its TLS efficiencies were 
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compared with isolated lesions, L and Tg separately in human cells. It was obvious that the 
cytotoxicity during tandem lesion replication was greater than their isolated lesions. It was also 
revealed that, all the lesions were replicated through TLS mechanism, mainly with pol 𝝵 
coordinated with other TLS polymerases and that Tg is not a strong replication block in human 
cells. It was evident from the mutational data that, the predominant nucleotide incorporation 
opposite L in both tandem and isolated positions was deoxyadenine. This proves that the widely 
reported ‘A-rule’, nucleotide incorporation opposite abasic site was in fact followed in the TLS 
bypass of these oxidative abasic lesions. 
 
Chapter 5 focusses on the mutagenicity and cytotoxicity of oxidative stress induced 
formamidopyrimidine - deoxyguanine adduct, Fapy.dG in human cells. A detailed scheme for the 
formation of these adducts along with their 𝝰 and 𝝱 conformation anomers were shown. 
Predominantly, Fapy.dG adducts exists as a 𝝱 anomer in DNA, hence an oligonucleotide adduct 
was synthesized for the experimental purposes, was described. From the single TLS polymerase 
knockout data, it can be hypothesized that polymerases 𝝵, 𝝸, 𝝹 play important role in the error-
prone replication. Future work on double knockdown experiments will reveal the biological 
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CHAPTER – 2 







All the enzymes used for restriction digestion, phosphorylation, ligation, scaffold removal, 
proteolysis reactions were EcoRV, T4 polynucleotide kinase, T4 DNA ligase, T4 DNA 
polymerase, M13 helper phage, uracil DNA glycosylase, proteinase K, exonuclease III and their 
corresponding buffers were purchased from New England Biolabs (Beverly, MA).  𝝲-32P ATP 
used for 5' end oligonucleotide labeling, and autoradiography was purchased from Perkin Elmer 
Life Sciences (Shelton, CT). 
  
2.1.2 Chemicals: 
The chemicals and reagents of commercial grade used for preparation of gels, buffers and wash 
solutions were tris-base, sodium chloride, boric acid, acrylamide, N, N'-methylene bis-acrylamide, 
disodium EDTA, TEMED, Ammonium persulfate, urea, agarose, HEPES sodium salt, sodium 
hydroxide, sodium citrate dihydrate and media components for bacterial growth include tryptone, 
yeast extract, agar were purchased from Fisher scientific (Agawam, MA). Oligonucleotide 
hybridization buffer (PerfectHybTM 1X buffer) was purchased from Sigma-Aldrich (St. Louis, 
MO). Phenol-chloroform-isoamyl alcohol (25:24:1) solution for plasmid purification was 
purchased from Invitrogen (Carlsbad, CA). 
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2.1.3 Reagents and cells: 
Bacterial competent cells E.coli DH10B, DH12S for electroporation, mammalian cell culture 
media components such as Dulbecco’s modified eagle medium (DMEM), fetal bovine serum 
(FBS), non-essential amino acids (NEAA), penicillin-streptomycin solution, transfection 
components such as Opti-MEM reduced serum medium, LipofectamineTM 2000 were purchased 
from Invitrogen (Carlsbad, CA). Synthetic siRNA duplexes used in the inactivation of pol 𝝶, pol 
𝝹, pol 𝝸, pol 𝝵 as well as the DNA extraction kit (cat # 51306), one step RT-PCR kit (cat # 210210), 
QuantiTect SYBR green RT-PCR kit (cat # 204243), RNeasy plus kit (cat # 74134) to isolate 
DNA, from HEK 293T cells were purchased from Qiagen (Valencia, CA). 
HEK 293T cells were obtained from ATCC (Manassas, VA). The unmodified nucleotides 
(controls), scaffolds, oligonucleotide probes for hybridization and primers for sequencing were 
purchased from Integrated DNA technologies (Coralville, IA). Costar spin-X tubes from Corning 
(NY), Sep-Pak C18 cartridges from Waters corporation (Milford, MA), Amicon ultra filtration 
units from Millipore Sigma (Burlington, MA) were obtained and employed in plasmid and 









2.2 METHODS:  
 
2.2.1 Purification of oligonucleotides using polyacrylamide gel electrophoresis (PAGE): 
Modified oligonucleotides (adducts), unmodified (controls), scaffolds were purified using 16 %-
20 % denaturing polyacrylamide gel electrophoresis (PAGE). The gel was formed by free radical 
initiated co-polymerization of acrylamide and bis-acrylamide along with 7 M urea, aided by 25 % 
ammonium persulfate, catalyzed by TEMED in 1X TBE (tris-borate-EDTA) buffer. Samples in 
water, up to 30 micrograms were mixed with the formamide dye (containing xylene cyanol and 
bromophenol blue dyes) and loaded onto the gel and run at 2000 V for 5 h to resolve the bands. 
The bands were then visualized under UV light and the desired gel fragments were excised. The 
oligonucleotide samples were back extracted from gel bands using 1X TE (tris-EDTA) buffer and 
co-star spin-X columns to separate the gel fragments. The filtrate with the desired oligo was further 
desalted using Sep-Pak C18 cartridges and were eluted in 60 % Acetonitrile solution. The 
acetonitrile was removed, and the samples were concentrated using hispeed-vacuum system and 
the resulting oligos were quantified using nano-dropTM spectrophotometer. To check the purity of 
the oligonucleotides extracted, about 100 nanograms of the oligo was radiolabeled at 5' - end using 
𝝲- 32P ATP and was run on the 16 % PAGE gel under same conditions. After the run, the bands 
were visualized and analyzed by autoradiography. 
 
2.2.2 Plasmid quantification using agarose gel electrophoresis: 
The plasmid employed in this research was a circular, single stranded pMS2 of size 5137 bp.  The 
quality and the quantity of the plasmid extracted from E.coli was verified using 1.1 % agarose gel 
electrophoresis. The gel was formed by polymerization of the agarose powder in 1X TBE when 
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heated. The DNA samples were mixed with the 6X loading dye (NEB) and were run on the gel for 
3 h at 110 V. After the run, the gel was stained with ethidium bromide (10 mg/ml) and then allowed 
to de-stain in water to remove background. Then the bands were visualized under Bio-Rad UV gel 
documentation analysis system and the intensities of the desired bands were obtained. Their 
intensities were then compared to the standard to calculate the unknown plasmid concentration as 
follows: 
Unknown plasmid concentration (μg/μl) = (unknown plasmid band intensity / known plasmid  
                                                                band intensity) * known plasmid concentration. (μg/μl) 
 
2.2.3 Preparation of single stranded pMS2 plasmid:  
Single stranded circular pMS2 plasmid of 5137 bp was prepared from E.coli JM109 using M13 
helper phage which was reported in (1). The plasmid contains SV40, f1, ColE1 origins of 
replication which aids in its replication in both mammalian and E.coli cells. The vector also 
contains neomycin and ampicillin resistant genes which helps in the selection of transformants 
containing pMS2 vector.  
Firstly, electroporate 50 nanograms of double stranded pMS2 plasmid in E.coli DH12S cells under 
conditions-1.8 kV, 25 μF and 200 Ω. To the electroporated culture, 1 ml of pre-warmed SOC media 
was added and was revived by shaking at 230 rpm, 37 °C for 1 h. The revived culture was then 
plated on 1X yeast-tryptone (YT) media plates containing ampicillin and incubated for 16 h at 37 
°C to obtain single colonies. Next day, ~100 colonies were scraped and sub-cultured in 2 liters of 
1X yeast-tryptone liquid media containing ampicillin (100 μg/ml) and 1 ml of M13 helper phage. 
After 2 h of shaking at 250 rpm, 37 °C, add 15 ml kanamycin (5000 μg/ml) and continued shaking 
for up to 20 h. This phage-infected culture was centrifugated at 10 k rpm for 20 min at 4 °C twice, 
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to separate the pellet. To the supernatant, add 4 % (w/v) of PEG-8000 and 3 % (w/v) sodium 
chloride and stirred slowly at 4 °C to separate the phage particles. After 2 h of stirring, the solution 
was centrifugated at 10 k rpm for 30 min at 4 °C to precipitate the phage particles. The precipitate 
was resuspended in 1X tris-EDTA (TE) buffer and incubated with proteinase-K, 10 % SDS for 16 
h at 42 °C to precipitate the lysed phage proteins. DNA was back extracted from the mixture using 
phenol-chloroform-isoamyl alcohol solution. Briefly, the phenol solution was added 1:1 ratio to 
the DNA mixture and centrifugated at 14000 rpm for 20 min at room temperature and was repeated 
thrice. The top layer contains the plasmid and bottom layer contains the lysed proteins. Hence the 
top layer was collected and purified using 100 K MWCO Amicon ultra centrifugal filtration or by 
ethanol precipitation using ammonium acetate. The obtained plasmid DNA pellet was resuspended 
in water and quantified using 1.1 % agarose gel electrophoresis.  
                                                    
FIGURE 2.1 - Single stranded pMS2 vector with ColE1, SV40, f1 origins of replication and 





2.2.4 Construction of modified pMS2 vector with site specific incorporation of adducts: 
25 micrograms of single stranded pMS2 plasmid contains a restriction site (5' GAT-ATC 3') which 
was digested by EcoRV enzyme to yield a gapped plasmid. A 62-mer PAGE purified scaffold, 
designed to be complementary to the adduct and the flanking sequences of pMS2 plasmid, was 
annealed at 75 °C to the gapped plasmid, allowed to cool down to room temperature. Then, a 30-
fold PAGE purified adduct oligonucleotide/control was phosphorylated at 5' end using T4 
polynucleotide kinase enzyme at 37 °C for 1 h and then ligated to the scaffold-annealed pMS2 
plasmid using T4 DNA ligase enzyme at 16 °C for 18 h to form phosphodiester bonds with the 
plasmid. Following ligation, the scaffold was removed by treating with uracil-DNA glycosylase 
and exonuclease III for 16 h at 16 °C.  After each step, an aliquot of the plasmid was run on 1.1 % 
agarose gel to confirm the completion of the reaction. Following de-scaffolding step, the modified 
constructs were extracted using phenol-chloroform solution and ethanol precipitation. The 





SCHEME 2.1: Protocol for the construction of recombinant vector with the oligonucleotide 





2.2.5 Transfection of recombinant vector in human cells: 
HEK 293T cells were cultured in Dulbecco’s Modified Eagle Medium (DMEM), 10 % Fetal 
Bovine Serum (FBS), 2.4 % non-essential amino acids (NEAA) and maintained at 37 °C, 5 % 
CO2. A 24-well plate was prepared and allowed to grow until 50 % confluency. Then, the adducted 
vector along with the control was transfected using lipofectamine-2000 and opti-MEM reagents. 
After 24-48 h, the cells attained 100 % confluency were harvested using 𝝱-mercaptoethanol and 
RLT lysis buffer (Qiagen), then stored at -80 °C until next step. 
 
2.2.6 Translesion synthesis (TLS) polymerase knockdown using siRNA transfection in 
human cells: 
HEK 293T cells were cultured and maintained under same conditions as mentioned above. A 6-
well plate was prepared and allowed to grow until 50 % confluency, 100 picomoles of first shot of 
synthetic siRNA duplex against the specific polymerase was transfected using lipofectamine-2000 
and opti-MEM reagents. After the cells have reached full confluency, they were sub-cultured into 
24-well plates and allowed to grow until 50 % confluency. Followed by co-transfection of 
adducted vector/control and 30 picomoles of second shot of siRNA duplex. After 24-48 h, when 
the cells reach full confluency, they were harvested using 𝝱- mercaptoethanol and RLT lysis buffer 




Gene siRNA (sense) sequence 
pol H 5' – GGUUGUGAGCAUUCGUGUATT - 3'  
pol K 5' – CUGUGAGUAAAGAGGUUAATT - 3' 
pol I 5' – GCCUCAUACAGUGAGAUUATT - 3' 
pol Z 5' – GCAAUUUUGAACCUUAUGGTT - 3'  
Rev 1 5' – CGGUGGAAUCGGUUUGGAATT - 3' 
TABLE 2.1: Represents the specific siRNA sequences designed and used in the single/double/ 







SCHEME 2.2: Represents the siRNA induced knockdown of TLS polymerases and transfection 
of recombinant vector in HEK 293T cells. Followed by transformation of harvested DNA in 
E.coli DH10B competent cells. 
2.2.7 Construction of TLS polymerase knockout cell lines: 
The single TLS polymerase knockouts were performed in HEK 293T cells using commercially 
available specific CRISPR/Cas9 knockout plasmids for pol 𝝶, pol 𝝸, pol 𝝹, pol 𝝵. These plasmids 
were transfected in cultured HEK 293T cells using the same procedure as described above. 
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Following transfection, single cells were sorted into 96-well plates using a BD FACSAria II flow 
cytometer. After clonal expansion, the monoclonal cell cultures were screened by western blotting 
for the protein expression levels. Similarly, the double knockout cell lines (pol 𝝶/𝝹) were 
constructed.  
2.2.8 Total RNA isolation and quantification: 
When the siRNA knockdown of TLS polymerases was performed in HEK 293T cells, it was 
important to note the efficiency of knockdown from the total RNA isolated by using RNeasy plus 
kit (cat # 74134). Total RNA was isolated according to the manufacturer’s recommended protocol. 
After 72 h of the siRNA transfection, HEK 293T cells were lysed by the addition of RLT buffer 
with 𝝱-mercaptoethanol and collected. The lysed cells (lysate) was homogenized by vortexing for 
1 min. Genomic DNA (gDNA) eliminator spin columns were used to isolate DNA from the lysate 
by centrifugation. To the filtrate, equal volume of ethanol was added. This mixture was passed 
through the RNeasy Min Elute spin column, to bind the RNA to the column by centrifugation. The 
column was washed with the wash buffers. RNA was eluted in water and quantified.                        
Total RNA quantification was performed by Nanodrop 2000c spectrophotometer, by adapting a 
convention in terms of absorbance. 1 unit of absorbance at A260 is equivalent to 40 μg/ml of RNA. 
Purity of the RNA can be tested by the 260/280 ratio which should ideally be 2.0, although 1.9 and 
2.1 are acceptable.  
2.2.9 Reverse transcription – polymerase chain reaction (RT-PCR) analysis: 
cDNA synthesis was performed by RT-PCR, using one step RT-PCR kit (cat # 210210) according 
to manufacturer’s protocol and literature (2). Briefly, 100 nanograms of total RNA isolated was 
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used as template, GAPDH as control, primers specific to the TLS polymerases were designed and 
listed below. Master mix was prepared by adding the primers, dNTP mix, enzyme mix buffer (Taq 
polymerase, Mg+2, K+, NH4+). Then the mix was distributed to the template containing tubes used 
for the thermocycler. First steps were to perform reverse transcription programmed at 30 min at 
50 ºC and PCR activation at 15 min at 95 ºC. The amplification steps - denaturation, annealing and 
extension were programmed at 94 ºC for 30 s, 55 ºC for 45 s, 72 ºC for 60 s respectively. 26 cycles 
were performed for pol 𝝶, pol 𝝸, pol 𝝹, Rev1; 32 cycles for pol 𝝵; 24 cycles for GAPDH. The RT-
PCR products were run on the 2 % agarose gel at 100 V for 3 hrs. 
Gene Primer Primer sequence 
pol H Forward 
Reverse 
5' – CTACTCGGGAACAGGTACAATG - 3' 
5' – GTGGGAGCAGTAAGAGATGAAA - 3' 
pol K Forward 
Reverse 
5' – AGCTGTGAGTAAAGAGGTTAAGG - 3' 
5' – TGAACCTAGACCCAAGGAGATA - 3' 
pol I Forward 
Reverse 
5' – ATTAGGGACAGGAAATTATG - 3' 
5' – CAATGTCAGAAGGGAAAAG - 3' 
pol Z Forward 
Reverse 
5' – GAGAGAAGCACAAGTCCCATAAA - 3' 
5' – CTAATGGGCTCTGCTGTAGATC - 3' 
Rev 1 Forward 
Reverse 
5' – AATCTACCAGGAGTTGGA - 3' 





5' – ACCACAGTCCATGCCATCAC - 3' 
5' – TCCACCACCCTGTTGCTGTA - 3' 





2.2.10 Real-time quantitative RT-PCR: 
Another method for synthesis of cDNA from total RNA as well as to quantify was obtained by 
performing real-time quantitative RT-PCR. The instrument used was Bio-Rad CFX-96 Real-Time 
PCR detection system using QuantiTect SYBR Green RT-PCR kit (cat # 204243) and protocol 
according to the manufacturer’s instructions.  Gene expression was quantified using cycle 
threshold method (2-ΔΔCT). SYBR Green PCR master mix was provided and the primers were 
added. This mixture was distributed to the PCR tubes containing the template/control. The cycles 
were programmed as follows: reverse transcription at 50 ºC for 30 min, PCR activation step at 95 
ºC for 15 min for one cycle each, amplification steps-denaturation at 94 ºC for 15 s, annealing at 
55 ºC for 30 s, extension at 72 ºC for 30 s for 40 cycles. 
2.2.11 Western blot analysis:  
After the siRNA polymerase knockdown (KD)/CRISPR-Cas9 polymerase knockout (KO) was 
performed, the gene silencing was confirmed by western blot analysis as per literature (2). After 
48 h of the KD/KO, the cells were lysed and collected in ice cold RIPA buffer containing protease 
inhibitor cocktail. The cell suspension was incubated for 1 h on ice and centrifuged at 10000 rpm 
for 15 min at 4 ºC. The concentration of the proteins in the supernatant (whole cell lysate) was 
determined by Bradford protein assay. Whole cell lysates were boiled in the loading buffer, 
containing 250 mM tris (pH 6.8), 5% SDS, 30 % glycerol, 20% 𝝱- mercaptoethanol, bromophenol 
blue. The proteins are resolved by 5 %-7 % SDS-PAGE gel, run for 2 h. The gel bands were 
transferred onto PVDF membranes and blocked with 5 % milk. These membranes were incubated 
with polymerase specific primary antibodies, with human 𝝱-actin antibody as control. Then the 
complexes were incubated with HRP-conjugated goat anti-rabbit, secondary antibodies. A 
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substrate, Pierce ECL western blotting substrate was employed for the purpose of 
electrochemiluminescence detection and the images were developed using Bio-Rad Personal 
molecular imager (PMI) phosphorimager.  
2.2.12 Double stranded DNA extraction from HEK 293T cells: 
Harvested cells after transfection stored at -80 °C were thawed rapidly at 37 °C. The samples were 
treated with the Qiagen columns (Cat # 51306) for the extraction of the double stranded DNA. 
Briefly, the columns with the samples were spun at 10000 rpm for 1min at room temperature to 
trap the DNA to the column. Then the column was washed with wash buffer-1 and wash buffer-2 
at 14000 rpm for 2 min. The DNA was eluted from the column with elution buffer (pre-heated at 
70 °C) at 10000 rpm for 1 min.  
2.2.13 Electroporation of double stranded DNA (dsDNA): 
The dsDNA extracted from the previous step was transformed into E.coli DH10B 
electrocompetent cells and the culture was revived in 1 ml SOC media by shaking at 37 °C, 230 
rpm for 1 hr. This culture was plated onto 1X YT plates containing ampicillin and incubated for 
16 h at 37 °C to obtain single colonies. Bacterial single colonies were picked and grown in the 
liquid 1X YT media containing ampicillin for 4 h at 37 °C, until log phase.  
 
2.2.14 Replication and fixation of double stranded DNA onto Whatman filters: 
The sub-cultured bacteria were blotted onto Whatman filter paper using replicator, were allowed 
to grow on the filter paper for 18 h at 37°C. These filters were washed with a series of wash 
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solutions which lysed the bacteria and released the DNA. Briefly, the filters were first treated with 
0.5 N NaOH for 5 min, followed by 0.5 M tris-HCl (pH 7.7) for 4 min. Then the filters were treated 
with 2X SSC (saline sodium citrate) for 2 min and finally with 200 proof ethanol for 1 min. After 
each wash, the filters were blotted to remove the excess solution and then briefly air-dried. The 
released DNA was then fixed onto the Whatman filters by heating up to 80 °C until they were 
absolutely dry.  
2.2.15 Mutational screening by Southern blot hybridization:  
Three oligonucleotide probes were designed with the sequences complementary to the 
adduct/control containing DNA replicated in HEK 293T cells. They were named as left probe 
(LP), right probe (RP) and wild type probe (WT) as shown below. These probes were radiolabeled 
using 𝝲-32P ATP at 5' end using T4 polynucleotide kinase enzyme at 37 °C for 1 h. Following this, 
the radiolabeled probes were allowed to hybridize to the adduct/control containing DNA, fixed on 
the filters, in hybridization buffer for 10 h at their specific melting temperature (49 °C/50 °C). 
Following hybridization, the filters were washed at the same hybridization temperature using pre-
heated 2X SSC buffer, twice to remove the background. The filters were then exposed to the screen 
to capture the image using Bio-Rad personal molecular imager (autoradiography).  
In the image obtained, the presence of the signals at the specific transformants reflects the binding 
of a particular probe to the DNA. To screen the mutants, first, the transformants that bind to both 
RP and LP were considered as those that contain the adduct/control DNA and the others were 
excluded. Then, the transformants that failed to bind to the WT but bound to RP/LP are identified 
and termed as mutants as the modification of the sequence has resulted in the failure of 
hybridization of probe. Hence, these mutants were sent for commercial sequencing analyses using 
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specific pMS2 primer designed to identify the specific position and the type of the mutation 
occurred.  
         
SCHEME 2.3: Protocol for performing mutational screening by Southern blot hybridization 










FIGURE 2.2: Represents a typical image obtained post-hybridization by autoradiography. The 
signals represent the hybridization of corresponding probe to the adduct/control. The red arrows 








Sequence of the adduct/control (Fapy.dG) 5' - GTG CGT GTT TGT – 3' 
Left probe (LP) 5' – GGT ACC AGC GAT GT - 3'  
Wild type probe (WT) 5' – TGT GCG TGTT TGT AT – 3' 
Right probe (RP)  5' – TGT ATC GCT TGC AG – 3' 
pMS2 primer used for DNA sequencing 
(reverse) 
5' – AGA ACC TGC GTG CAA TCC -3' 
TABLE 2.3: Sequences of probes designed specifically for an adduct/control (eg. Fapy.dG) for 
Southern blot hybridization with melting temperature at 49 ºC. A reverse primer designed for 















2.2.16 TLS efficiency: 
TLS efficiency of the adducts when replicated in the different kinds of cells was calculated to 
understand how knockout (KO) or knockdown (KD) or specific polymerases affect the replication. 
To achieve this, adducted pMS2 constructs were transfected along with the internal control (IC) 
constructs in 1:1 ratio. IC constructs are the unmodified constructs with altered sequence. After 
amplification in E.coli, the progeny was analyzed by Southern blot hybridization using 
oligonucleotide probes specific to adduct and IC. TLS efficiency was calculated as the percentages 
of the colonies from replication of the adduct to the IC. 
TLS efficiency (%) = (# signals of adduct / # signals of IC) * 10 
Sequence of Internal control  5'- AGG GTT TAC CCA GTC ACG ACG TT – 3' 
IC probe 5' – TAC CCA GTC ACG ACG – 3' 
TABLE 2.4: Represents the sequence of internal control used to calculate TLS efficiency and 
the corresponding IC probe designed for Southern blot hybridization. 
 
2.2.17 Primer extension assay using human replicative polymerases: 
Primers were radiolabeled at 5' end with 𝝲-32P ATP as described above. The DNA templates 
(adduct and control) were annealed with labeled primers. These primer-template complexes (1 
pmol) were incubated with the mixture of 1 mM of four dNTPs. The buffer used in this assay with 
the composition of 25 mM tris/HCl (pH - 7.5), 8 mM MgCl2, 5 mM DTT, 100 μg/ml BSA and 10 
% glycerol. The polymerization reaction was initiated by addition of either 0.56 pmol of pol 𝝳 or 
pol 𝝴 to the primer-template solution. At certain time intervals (0 min, 5 min, 15 min, 30 min), 
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aliquots were collected, and the reaction was quenched by the addition of the gel loading buffer 
(20 mM EDTA in 95 % formamide, 0.05 % bromophenol blue, 0.05 mM xylene cyanol). The 
samples were then run on the 20 % denaturing PAGE gel at 80 W for 2 h to resolve the primer 
excision bands. The bands were then visualized using autoradiography.   
2.2.18 Single-nucleotide incorporation assay: 
Primers were radiolabeled at 5' end with 𝝲-32P ATP as described above. The DNA templates 
(adduct and control) were annealed with labeled primers. These primer-template complexes (1 
pmol) were incubated with the mixture of 1 mM of four dNTPs. The buffer used in this assay with 
the composition of 25 mM tris/ HCl (pH 7.5), 8 mM MgCl2, 5 mM DTT, 100 μg/ml BSA and 10 
% glycerol. The reaction was initiated by the addition of a single dNTP (dATP, dTTP, dGTP, 
dCTP). At certain time intervals (0 min, 5 min, 15 min, 30 min), aliquots were collected, and the 
reaction was quenched by the addition of the gel loading buffer (20 mM EDTA in 95 % formamide, 
0.05 % bromophenol blue, 0.05 mM xylene cyanol). The samples were then run on the 20 % 
denaturing PAGE gel at 80 W for 2 h to resolve the primer excision bands. The bands were then 
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CHAPTER – 3:  
Error-prone replication of a 5-formylcytosine-mediated DNA 
































DNA protein cross-links (DPCs) are formed when proteins covalently bound to DNA (1, 2). Their 
formation was first reported in 1960s (3). DPCs can be induced by exposure to exogenous agents 
such as anti-tumor drugs, transition metals and UV light or endogenously by cellular processes 
such as lipid peroxidation, histone demethylation, DNA replication, transcription, and DNA repair 
(1, 2, 4-9). They interfere with the chromatic architecture (10), DNA repair, block DNA replication 
and transcription. DPCs are toxic and induce mutations (1, 2, 4, 5, 11-13) when replicated, which 
leads to cancer and aging (14-17). Initial steps of DPC repair are presumed to involve proteolytic 
digestion of cross-linked protein into its peptide fragment. This small peptide fragment, termed as 
DNA peptide cross-link (DpC) can be repaired by NER (12, 18, 19) or if unrepaired, bypassed by 
TLS mechanism (18, 19). Other mechanisms such as NER, homologous recombination and 
fanconi anemia pathways involve in the DPC repair with/without the proteolytic processing (11, 
19, 20). Recent discovery of DNA-dependent mammalian protease, SPRTN (SprT-like N-terminal 
domain) is required to proteolyze DPC in vivo. It was observed that the function of SPRTN was 
compromised in Ruijs-Aalfs syndrome patients suffering from accelerated aging and increased 
incidence of liver cancer (21).  
Epigenetics is the term used to define the interaction of the genome and the environment, which 
influences the gene expression in higher organisms (22). Epigenetic modifications are inheritable, 
occur as a result of DNA methylation, histone modification and nucleosome positioning (23). 
These are important in the cellular mechanisms including micro-RNA expression, DNA protein 
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cross-link formation, suppression of transposable element mobility, cellular differentiation, 
embryogenesis, X-chromosome inactivation and genomic imprinting (23). They also play an 
important role in the cancer initiation and progression. One of the common bases which undergo 
methylation in humans is deoxycytosine (dC) to form 5-methylcytosine (5mC), catalyzed by 
DNMT family of enzymes (23, 24). 5mC undergo oxidation to form 5-hydroxymethylcytosine 
(5hmC), which on further oxidation in a stepwise reaction form 5-formylcytosine (5fC) and 5-
carboxycytosine (5caC) by the action of TET (ten-eleven translocation) family dioxygenases (24) 
as shown in scheme 3.1. Low levels of 5fC bases have been detected in all mammalian tissues (25-
27). It was recently discovered that 5-formylcytosine (5fC) forms reversible Schiff base conjugates 
with histone proteins; these can be reductively stabilized to form stable amino conjugates (28, 29). 
5fC forms reversible Schiff base cross-links with histone proteins both in vitro and in human cells 
to form DNA protein cross-links (DPC), which influences the gene expression levels in humans 
(28, 29). These DPCs are acted upon by the proteolytic enzymes which result DNA peptide cross-
links (DpCs). In this research, we studied the mutagenicity and toxicity induced by adduct, 5fC-
















SCHEME 3.1: Methylation and oxidation of cytosine by DNMT transferases and TET-family  
dioxygenases respectively to form 5-formylcytosine. 
 
 
In comparison, relatively little is known about the interactions of DPCs with DNA replication 
machinery. Although in the early 1990s DPC formation and mutagenesis in mammalian cells were 
shown (30), the majority of the reports published subsequently either failed to link formation of 
DPCs with mutations (31, 32) or suggested that DPCs may not induce mutagenesis in mammalian 
cells (32). More recent research using advanced tools, however, established that DPCs containing 
large proteins completely block replicative bypass but that peptide containing DpCs allow TLS 
(11, 33-39).  
Our previous studies with a model DpC have established a key role of TLS polymerases, such as 
hpol 𝝹 and 𝝶, in catalyzing DNA replication past DpC lesions (37). Unlike replicative 
polymerases, whose tight active sites undergo conformational changes upon binding the correct 
dNTP, TLS polymerases of the Y family have more open sites that enable them to bypass bulky 
DNA lesions (40, 41). We found that 5fC conjugated to histones H2A or H4 completely inhibited 
      






DNMT TET TET 
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DNA replication in vitro but that TLS by Y-family polymerases occurred when the proteins were 
subjected to proteolytic digestion (38). 5fC-mediated cross-links to 11-mer or 31-mer peptides 
were bypassed by hpol 𝝶 and 𝝹 in an error-prone manner, including targeted C->T transitions and 
(-1) frameshift deletions. Similar mutations also occurred when a plasmid containing the 11-mer 
DpC is replicated in HEK 293T cells (38).  
The main purpose of this work was to establish the roles of the TLS DNA polymerases in both 
error-free and error-prone bypass of DpCs in living cells. We examined replication of a plasmid 
containing a site-specific, structurally defined cross-link between 5fC and an 11-mer peptide in 
HEK 293T cells as well as in the cells subjected to knockout and/or knockdown of one or more 
TLS polymerase(s). To focus on replication rather than repair, we employed a single-stranded 
plasmid with DpC, as DNA damages in single-stranded DNA are refractory to repair by most 
common types of DNA repair pathways. We have also investigated the ability of hpol 𝝳 and 𝝴 to 
bypass the DpC lesion in vitro.  
 
3.2 SYNTHESIS OF DpC: 
A 23-mer oligodeoxynucleotide (5'-AGG GTT TTC CXA GTC ACG ACG TT-3'), where X 
represents 5fC covalently bonded to an 11-mer peptide at lysine (K), RPKPQQFFGLM-CONH2, 
was synthesized and characterized as described in the literature (28). The procedure for preparation 
was outlined briefly in scheme 3.2, and its characterization and purity were performed by MS. The 
aldehyde group of 5fC forms a reversible Schiff base with the side chain of the third amino acid, 
lysine, of the polypeptide, which was stabilized by NaCNBH3 reduction. The oligonucleotide-
polypeptide conjugate was purified by electrophoresis on a 20 % polyacrylamide gel containing 7 
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SCHEME 3.2: Preparation of 5fC-conjugated DNA peptide cross-link by forming Schiff base 




3.3.1 Replication of DNA peptide cross-link in human cells: 
 
 
The DpC-containing 23-mer oligonucleotide (5fC-DpC in Scheme 3.2) was ligated into a gapped 
pMS2 plasmid for 18 h at 16 ºC, followed by 14 h at 4 ºC, to generate a recombinant plasmid 
vector. Prior to the ligation, the 5fC-DpC was phosphorylated twice for 1 h each time at 37 ºC to 
increase the efficiency of the reaction. The DpC construct and an unmodified plasmid (containing 
a different sequence at the ligation site) were co-transfected into HEK 293T cells. The unmodified 
vector served as an internal control of transfection efficiency. Following 24 h incubation, where 





E.coli DH10B cells (Scheme 3.3). The resultant colonies were analyzed by oligonucleotide 







SCHEME 3.3: Recombinant pMS2 vector construction with 23-mer DNA peptide cross-link 
adduct followed by mutational screening using Southern blot hybridization and confirmed by 
DNA sequencing.  
 
3.3.2 Complete mutation profile induced by DpC and role of TLS polymerases:  
The figure represents the complete mutation profile of DpC in HEK 293T cells and in various 
polymerase (pol)-deficient cells. The mutations obtained were categorized into targeted and semi-
targeted mutations as shown in figure 3.1. Targeted represents the base substitutions/deletions at 
the lesion-bearing site. Semi-targeted represents the base substitutions/ deletions at the 5' and 3' 
flanking regions of targeted site. Nearly 14 % of plasmid progeny recovered from HEK 293T cells, 
transfected with the DpC-vector were mutants, which included 9 % targeted and 5 % semi-targeted 
base substitutions and frameshift mutations (deletions). Knockout/knockdown (KO/KD) of TLS 
polymerases resulted in reduced mutation frequency (MF) upon replication past DpCs, which was 
most pronounced upon knockdown of either hPol 𝝸 or hPol 𝝵. Targeted mutations were reduced by 
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50 %-80 %, from 8.6 ±1.9 % in HEK 293T cells to 2.9 ± 0.4 % in pol 𝝸 KD cells. Similarly, it was 
reduced to 3.2 ± 0.6 % in pol 𝝵 KD cells, a reduction of 45 %-75 %. Then, a double knockdown 
of pol 𝝸/𝝵 was performed and the MF was not further reduced. Various pol-deficient cells were 
generated by siRNA knockdown and CRISPR-Cas9 techniques, in which DpC-vector was 
replicated. Among these double polymerase KO/KD experiments, pol 𝝸/𝝵 KD and pol 𝝶/𝝹 KO 
show similar reduction in the MF. Further, replication of DpC-vector in triple polymerase KO/KD 
cells was performed and the maximum reduction in MF was observed when the cells are devoid 
of polymerases 𝝶/𝝹/𝝵. Here in pol 𝝶/𝝹/𝝵 KO/KD cells, the MF was reduced from 13.5 ± 1.7 % in 


















FIGURE 3.1: Targeted and semi-targeted mutations induced in the progeny from the 5fC–
linked DpC construct in HEK 293T (293T) and various polymerase KO or KD cells (as 
indicated). The data represent the mean and standard deviation (of total MF) from two to five 
independent experiments. The statistical significance of the difference in MFs between HEK 
293T and TLS pol knockouts and/or knockdowns (KD) was calculated using two-tailed, 





Of the four types of targeted mutations, the prevalent ones found in all the experiments were  
C->T and C-deletion as shown in figure 3.2. Other infrequent mutations were C->G, C->A. In 
293T cells, targeted mutations were comprised of 6.7 % C->T transitions, 0.6 % C->G 
transversions, and 1.3 % targeted C deletions. Similarly, C->T mutations were reduced by 40 %-
80 % and 30 %-70 % upon single knockdown of hPol 𝝸 and hPol 𝝵 respectively. With reference to 
the total MF data, C->T mutations were reduced to 1.4 ± 0.2 % in triple KD/KO of pol 𝝶/𝝹/𝝵 cells 











FIGURE 3.2: The types and frequencies of targeted mutations induced in the progeny from the 
5fC-linked DpC construct in HEK 293T cells and various polymerase KO or KD cells (as 
indicated). The data represent the mean and standard deviation (of the total targeted MF) from 
two to five independent experiments. The statistical significance of the difference in targeted 
MFs between HEK 293T and TLS pol knockouts (KO) and/or knockdowns (KD) was calculated 





Semi - targeted base substitutions and 1 - 6 base deletions around the DpC site comprised ~33 % 
of total mutations in HEK 293T cells. Nearly half of the semi-targeted mutations were 1 - 6 base 
deletions, whereas insertion mutations did not occur. Of the various semi-targeted base 
substitutions, C–>T at several different cytosine sites in the adduct were predominant. Upon 
knockout and knockdown of TLS polymerases, the frequency of semi-targeted mutations 
decreased in some cases, but no clear pattern emerged, and the changes were not statistically 
significantly different. In some knockout/knockdown experiments, the percentage of semi-targeted 
mutations increased to more than 50 % of the total mutations. Taken together, the results from 
TLS polymerase knockout/knockdown experiments are indicative of an involvement of TLS 
polymerases hPol 𝝸, hPol 𝝶, hPol 𝝹, and hPol 𝝵 in error-prone bypass of 5fC-mediated DpC lesions 
in human cells. 
3.3.3 TLS efficiency:  
Figure 3.3 represents the bypass efficiency of DpC in HEK 293T cells, along with various 
experiments of single/double and triple knockout/knockdown of TLS polymerases (pol 𝝶, pol 𝝵, 
pol 𝝹, pol 𝝸). TLS efficiency was determined as the percentages of the colonies recovered from the 
lesion-containing plasmid relative to the internal control. In HEK 293T cells, the replication 
efficiency of the DpC-containing plasmid was 98.5 ± 1% compared with an unmodified control 
plasmid (set as 100 %).We next examined the effects of 5fC-DpCs on DNA replication in various 
TLS polymerases-deficient cells (hPol 𝝶, hPol 𝝵, hPol 𝝹, and hPol 𝝸). Surprisingly, the TLS 
efficiency did not change upon knockout of hPol 𝝶 and hPol 𝝹 or knockdown of hPol 𝝸 and hPol 
𝝵. TLS remained above 93 % even in double and triple knockout/knockdown of TLS polymerases. 
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This indicates that TLS polymerases are not required for bypass of 5fC-DpCs in human cells and 














FIGURE 3.3: The extent of replicative bypass (or TLS efficiency) of 5fC-linked DpC in HEK 
293T cells with or without various TLS polymerases. Percent TLS of the DpC construct in 
different polymerase knockout or knockdowns was measured relative to an internal control 
DNA. The data represent the mean and standard deviation of results from three independent 
experiments. HEK 293T cells were treated with negative control siRNA (293T), whereas the 









3.3.4 In vitro replication of a DpC lesion by replicative DNA polymerases 𝝳 and 𝝴 using 
primer extension assay: 
Our observation of efficient replicative bypass of the 5fC-linked DpC lesion in HEK 293T cells 
even with radically reduced levels of TLS polymerases suggests that these specialized polymerases 
are not required for DpC lesion bypass in human cells. Therefore, we investigated the possibility 
that this bulky adduct can be bypassed by replicative DNA polymerases 𝝳 and 𝝴. Standing-start in 
vitro primer extension assays were conducted in the presence of hPol 𝝴 (left panel) and hPol 𝝳 
(right panel) as represented in the figure 3.4. Primer–template complexes were created by 
annealing 
32
P-labeled 12-mer primers to the 23-mer template containing 5fC control or the 11-mer 
peptide DpC. In vitro replication was initiated by the addition of the corresponding DNA 
polymerase and a mixture of dNTPs. Primer extension reactions were quenched at selected time 
points prior to loading onto 20 % denaturing polyacrylamide gel. 
As shown in figure 3.4, recombinant hPol 𝝴 (left panel) was able to extend the primer past 
unconjugated 5fC to form a full-length 23-mer product, although a significant fraction of the 
primer remained unchanged, even after a 30-min reaction. Primer extension using the DpC 
template was even less efficient, but a small part of the full-length product was formed in 5 min, 
which gradually increased over a 30-min time period. In comparison, hPol 𝝳-catalyzed replication 
of the control template was significantly more efficient, with more than 95 % of the primer 
extended to the full-length product in 5 min (right panel). Primer extension using the DpC-
containing template was much slower, but the band corresponding to the full-length product 
continued to increase during the 30 min incubation. This suggests that both hPol 𝝴 and hPol 𝝳 can 
bypass the 5fC-conjugated DpC, albeit more slowly than the 5fC control. In addition, both 
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replicative polymerases exhibited exonuclease activity, so a significant portion of the primer were 








FIGURE 3.4: Primer extension assays for replication bypass of 5fC-mediated DNA peptide 
cross-links by hpol 𝞮 and hpol 𝞭 (A-D), the 32P-labeled 12-mer primer was annealed with a 23-
mer template containing 5-formyl-dC (A and C) or the 11-mer peptide cross-link 
RPKPQQFFGLM (B and D). Polymerase reactions were initiated by addition of DNA 
polymerases and a mixture of dNTPs and quenched at selected time points prior to loading onto 
20 % denaturing PAGE. 
 
3.3.5 Fidelity of replication of a DpC lesion by replicative DNA polymerases 𝝴 and 𝝳 by 
nucleotide incorporation assay in vitro: 
Figure 3.5 & 3.6 represent the single nucleotide insertion experiments conducted, to investigate 
the fidelity of hPol 𝝴 and hPol 𝝳 respectively upon in vitro replication of the DpC-containing 
template. For hPol 𝝴, the correct nucleotide (dGTP) was preferentially incorporated opposite both 
DpC and the 5fC control. Gel electrophoresis analyses revealed that three successive dGs were 
incorporated because of the 3'-XCC sequence of the template strand. 
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Although low levels of dTTP and dATP misincorporation were noted opposite 5fC, no noticeable 
misincorporation opposite DpC was detected. Similar results were obtained for hPol 𝝳- dGTP was 
the only nucleotide inserted opposite DpC, whereas dGTP and low levels of dATP were 
incorporated opposite the 5fC control. To determine the catalytic efficiency of dGTP incorporation 
by hPol 𝝳 opposite DpC and 5fC, steady-state kinetic experiments were conducted. The same 
primer–substrate complexes were used, and the primer extension reactions were conducted in the 
presence of hPol 𝝳 with increasing concentrations of dGTP (5-500 μM) as shown in the figure. To 
ensure steady-state conditions, a 9-90 molar excess of DNA over hPol 𝝳 was employed. Steady-
state kinetic parameters were determined from Michaelis-Menten curves (Table 3.1). kcat/Km 




, respectively, indicating that the presence of the peptide lesion significantly inhibits DNA 
polymerase activity. Overall, these results revealed the ability of replicative DNA polymerases to 
catalyze error-free nucleotide addition opposite 5fC derived DpC lesions. Perhaps this is not 
surprising, as such lesions routinely form at epigenetic marks in human cells and, thus must be 
tolerated by the cellular machinery.  
 
TABLE 3.1: Steady-state kinetics parameters for single-nucleotide incorporation opposite 5fC 




Polymerase Template Incoming 
nucleotide 
Kcat (min-1) Km (μM) Kcat/ Km (μM-1 min-1) 
hPol 𝝳 5fC dGTP 1.30 ± 0.08 23 ± 5 0.056 ± 0.013 
 11 - mer 
peptide 


















FIGURE 3.5: Single-nucleotide insertion opposite 5fC (control) and the 5fC-11-mer peptide 
cross-links by hpol 𝞮. Template-primer complexes were incubated with hpol 𝞮 in the presence 
of individual dNTP and then quenched at preselected time points. X denotes 5 -formylcytosine 























FIGURE 3.6: Single-nucleotide insertion opposite 5fC (control) and the 5fC-11mer peptide 
cross - link by hpol 𝞭. Template-primer complexes were incubated with hpol 𝞭 in the presence 
of individual dNTP and then quenched at pre-selected time points. X denotes 5-formylcytosine 








DPC formation in cells was first reported as early as in the 1960s (3). In the early 1990s, it was 
shown that vanadate (VO3
- ) produces DPCs and causes mutations in mammalian cells (30). Most 
other reports in the latter part of the 20th century, however, either failed to associate formation of 
DPCs with mutations (31, 32) or indicated that DPCs cause cytotoxicity and clastogenicity but 
may not induce mutagenesis in mammalian cells (42). Research in the last two decades, in contrast, 
unambiguously established that DPCs containing large proteins pose strong blocks of DNA 
replication, whereas certain peptide-containing DpCs allow error-prone replicative bypass both in 
vitro and in vivo (11, 33-38). For example, Lloyd and coworkers (34, 43) have shown that DpCs 
covalently linked to the N
2 position of dG blocked DNA replication, whereas the same peptide 
conjugated to the N
6 position of dA was bypassed and induced small number of mutations in both 
E. coli and simian kidney cells. In vitro studies showed that E. coli pol II, pol III, and pol V cannot 
replicate past these DpCs but that pol IV is reasonably proficient in their bypass (34). Moreover, 
Pol 𝝹 is highly efficient and accurate in TLS of the dG-N
2
-DpCs, as it is with other dG-N
2 adducts 
(34). Indeed, the types and frequencies of DPC - induced mutations appear to be strongly 
dependent on the site and structure of the cross-links as well as the types of cells in which they are 
replicated. We have shown that site-specifically modified templates containing 10 to 20-mer 
peptides conjugated to uracil, 7-deazaguanine, or 5fC, unlike full-length protein DPCs, are subject 
to bypass by Y-family DNA polymerases. Although proteins and large peptides ( >20 amino acids) 
conjugated to the C5 position of dT completely blocked Pol 𝝶 and 𝝹, smaller C5-dT DpC 
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conjugates (<10-mer peptides) were bypassed in an error-prone manner, giving rise to large 
numbers of deletions and point mutations (35, 44).  
Depletion of one or more TLS DNA polymerases has become an attractive approach to determine 
their role in lesion bypass, which we employed in this study. A limitation, however, was that we 
were able to generate only a limited number of knockout cell lines and used the siRNA knockdown 
approach for the rest. A strict comparative quantitative analysis, therefore, is unwarranted. Even 
so, the critical role of TLS polymerases in the mutagenic outcome was evident.  
In one of our earlier reports, TLS efficiency of a model DpC containing a 10-mer Myc peptide 
covalently linked to C7 of 7-deaza-dG was 76 % in HEK 293T cells compared with 100% progeny 
derived from the control DNA, suggesting that this lesion slowed down DNA replication (37). In 
contrast, DpCs conjugated to the C5 position of 5fC examined in this study, allowed a TLS 
efficiency comparable with that of the 5fC control in HEK 293T cells. Additionally, TLS 
efficiency was barely altered in cells with or without TLS polymerases, suggesting that none of 
these polymerases were essential for TLS of the C5-5fC-conjugated DpC lesion. This led us to 
hypothesize that C5-5fC DpC-containing DNA may be bypassed by replicative DNA polymerases. 
Indeed, in vitro replication experiments with recombinant hPol 𝝳 and hPol 𝝴 revealed that both 
polymerases can catalyze DNA synthesis past the 5fC-linked 11-mer peptide lesion, albeit more 
slowly than 5fC. Remarkably, nucleotide incorporation opposite the DpC by hPol 𝝳 and hPol 𝝴 
was accurate, and no nucleotide misincorporation opposite the lesion was detected. Overall, our 
results indicate that hPol 𝝳 and hPol 𝝴 can bypass the C5-5fC-conjugated DpC in an error-free 
manner. However, because of the low efficiency of bypass, TLS polymerases are likely to be 
recruited to the replication fork, leading to nucleotide misincorporations. The mechanism of 
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nucleotide misincorporation can be rationalized from our recent molecular dynamics’ simulations 
of the hPol 𝝶-DNA ternary complexes, which revealed that the 11-mer peptide can be 
accommodated in the DNA major groove side. It also showed that the adducted 5fC forms a stable 
pair with the incoming dATP via wobble base-pairing in the polymerase active site, thereby 
causing C->T transitions (38). The targeted C deletion, on the other hand, can be explained by a 
slippage mechanism, when the incoming dG opposite the adducted 5fC realigns to the 5'-adjacent 
C, thereby causing the one-base targeted deletion (38). The cellular mutagenesis results for 5fC - 
induced DpCs differ from our earlier findings for DpCs conjugated to the C7 of 7-deaza-dG (37). 
In that study, replication of DpC-containing plasmids produced both targeted (20 % targeted G-> 
A and G->T) and semi-targeted (15%) mutations in HEK 293T cells (37). TLS efficiency and 
targeted mutations were reduced upon siRNA knockdown of pol 𝝶, pol 𝝹, or pol 𝝵, indicating that 
they participated in error-prone bypass of 7-deaza-dG-linked DpC lesions (37). However, the 
semi-targeted mutations at G5 position were only reduced upon knockdown of pol 𝝵, suggesting 
its critical role in this type of mutations (37). Even though targeted and semi-targeted mutations 
were observed in both studies, each structurally distinct DpC exhibited a unique spectrum of 
mutations. We postulate that the semi-targeted mutations induced by DpCs arise from local 
destabilization of the DNA helix in the presence of bulky DpC lesions and from interference of 
nucleotide incorporations near the lesion site by the long arm of the peptide, which can adopt many 
different conformations. Future structural studies will likely shed light on the validity of this 
hypothesis and the mechanistic details of semi-targeted mutagenesis by the DpCs.  
Although this study was conducted with the 5fC-DpC situated in single stranded DNA, which is 
not repaired by most DNA repair systems, immediately after TLS, the DpC-containing plasmid 
may become a substrate for DNA repair. 5fC itself is repaired by base excision repair (45), whereas 
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the 5fC-DpC conjugate is likely to be an NER substrate (12, 18, 19). In this study, we did not 
attempt to determine the role of DNA repair in mutagenesis, but, in the future, it would be of 
interest to determine the interplay of DNA repair with mutagenesis induced by this DpC.  
3.5 CONCLUSION: 
In conclusion, our results indicate that polymerase bypass of 5fC-conjugated DpC lesions by TLS 
polymerases gives rise to mutations in human cells. Even for such bulky DNA adducts, the 
specialized bypass polymerases of the Y and B families are not required for bypass of the 5fC-
polypeptide cross-link. Replicative hPol 𝝳 and hPol 𝝴 could bypass the 5fC-linked 11-mer peptide 
lesion in an error-free manner. However, because of the low efficiency of DpC bypass by hPol 𝝴 
and hPol 𝝳, TLS polymerases are recruited to the replication fork, leading to nucleotide 
misincorporations and mutagenesis in human cells. 
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CHAPTER – 4 
Mutagenic Effects of a 2-Deoxyribonolactone -Thymine Glycol 






















4.1  INTRODUCTION: 
Reactive oxygen species (ROS) (1,2) are produced by various endogenous and exogenous agents. 
The hydroxyl radical (OH•), one of the highest generated radicals (1,3), interact with the DNA 
nucleobases to form a peroxyl radical (O-O•) at C5 position (4). Majority of the peroxyl radicals 
under aerobic conditions, react with the 5' or 3' adjacent nucleobases to form tandem lesions (4,5). 
Tandem lesions are contiguously damaged nucleotides present adjacent to each other in the DNA. 
These form an important part of the clustered DNA damages (5-7).  
In this chapter, the mutagenicity and cytotoxicity of tandem lesion (5'-LTg-3') comprising of 2-
deoxyribonolactone (L) & thymine glycol (Tg) was studied. Along with a compare and contrast 
study among 5'-LTg-3' and isolated lesions L and Tg, when replicated in human cells. Due to their 
close proximity of the DNA damages, the tandem lesions are more resistant to repair than their 
individual presence in the DNA (8).  
 
4.1.1 Formation of thymine glycol (Tg): 
Thymine glycol (Tg) is the most common oxidation product of thymine when exposed to ionizing 
radiation (9-11). OH•  radicals react with thymine at C5 and C6 position, forms two predominant 
isomers (5R, 6S) and (5S, 6R) (12,13) as shown in scheme 4.1. It is reported that the 5R and 5S 
isomers were formed in equal proportions as a result of 𝝲 - radiolysis, but oxidation of thymine 
results in the preferential 5R isomer (11,14). Hence, the replication bypass of 5R isomer was 
studied here. Upon the addition of hydroxyl groups at C5 and C6 positions, thymine loses its 
aromaticity to form a non-planar structure (11). Tg lesions in humans can be repaired by long patch 
BER (15,16), by the action of DNA glycosylase/AP lyase NTH1 (17) and to a small extent by 
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NER (16,18). Since all the Tg lesions cannot be repaired, they proceed to replication bypass which 
is carried out by TLS. 





                                               
 
 
SCHEME 4.1: Oxidation of thymine to form thymine glycol (Tg) isomers (5R, 6S) and (5S, 6R).  
 
4.1.2 Formation of 2-deoxyribonolactone (L): 
2-deoxyribonolactone (L) is the most common oxidized abasic sites found in the DNA (19-21). It 
is formed by the oxidation of C1' of an abasic site (19,20). C1' site is buried in the minor groove 
of the DNA rendering it less accessible for the oxidation to occur, hence the frequency of the 
formation of single independent lesion, L was reported to be very less (22,23). However, it is 
reported that the formation of L, as 5'-component of a tandem lesion is more frequent as the peroxyl 
radical on the 3' pyrimidine base component facilitates it (24-26). Formation of these peroxyl 
nucleobase radicals are more common, when exposed to 𝝲-radiolysis (26). Previous kinetics 
studies reported that the peroxyl radical mediated formation of L is favored 4-5 fold than the direct 
formation of L (27).  L is naturally formed when DNA is exposed to anti-tumor agents such as 
                                
H 
Thymine 
Thymine glycol isomers 
(5S, 6R) (5R, 6S) 
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NCS, because NCS binds to the minor groove of DNA and thereby overcomes the C1' 
inaccessibility (21,24,28).  
L is formed by either of the two processes proposed, which are two-electron and one-electron 
oxidations (29,30). Two-electron oxidation includes an intermediate nucleobase radical formation 
which proceeds to further oxidation to form L (31-33). The latter process begins with the direct H-
atom abstraction from the nucleobase (29,30). L is repaired by long-patch BER process, which is 
proceeded through strand displacement by polymerase 𝝱 and excision by FEN1 enzyme (15,34).  
 
4.1.3 Formation of tandem lesion (LTg): 
Tandem lesions are regarded as a major class of products formed from the pyrimidine nucleobase 
radicals, as a result of ionizing radiation (24-26). It should be noted that about 82 % of peroxyl 
radicals produced in this manner, will attack either 5' or 3' nucleotides to form tandem lesions, 
which depends on the radical bearing nucleobase (26,27,35-37). In this case, the peroxyl radical 
attached to thymidine can only abstract C1'-H atom from 5'-nucleotide. About 11 % of tandem 
lesions in the cells contains 2-deoxyribonolactone as the component with Tg (27). Tandem lesion 
(LTg) as a whole, is responsible for specific biochemical effects in the BER repair process in the 
cells. L-component forms DPCs irreversibly with the BER proteins, thereby inhibits their function 
(15,38). Particularly, the enzymes endonuclease III and DNA polymerase 𝝱 are crosslinked to 
DNA by the Schiff base formation with their lysine side chains (15,39). It also results in the 
increased formation of DSBs (40). Both isolated L and tandem LTg are alkali labile lesions which 
cleave when treated with NaOH (0.1 M, 37 ºC, 20 min) (41-43).  
The postulated mechanism (5,26-28) of formation of LTg is shown in scheme 4.2 and described 
below. When exposed to ROS, the OH• radical breaks the double bond, forms C5 - radical. Under 
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aerobic conditions, C5 radical transforms into a peroxyl radical. This peroxyl radical will further 
abstract the C1'-H atom from 5'-adjacent nucleotide to form 2-deoxyribonolactone (L), and dT into 
thymine glycol (Tg), thus results in tandem lesion (LTg).  

















SCHEME 4.2: Formation of tandem lesion (LTg), an oxidized abasic site resulted from the 







4.2  SYNTHESIS STRATEGIES:  
 
4.2.1 Synthesis of oligonucleotides containing Tg (44):  
To understand the implications in human cells, organic synthesis of these lesions was performed 
and were site specifically incorporated in the oligonucleotides. All the oligonucleotides used in 
this study, were of 16-mer length, synthesized on an Applied Biosystems Inc. 394 DNA 
synthesizer. The (5R,6S)-thymine glycol phosphoramidite was purchased from Glen Research Inc. 
and was deprotected as described in literature (5). The solution was treated with 3 M NH4OAc and 
EtOH for precipitation of modified oligo. The Tg - containing oligo was further purified by 20 % 








FIGURE 4.1: (5R, 6S) isomer of Tg-adduct in the sequence  









4.2.2 Synthesis of oligonucleotides containing L and LTg:  
Since L and LTg are alkali-labile lesions, the C1' site was protected by chemical groups which in 
turn serve as photochemical precursors (45-47). These precursors were site-specifically 
incorporated into a 16-mer oligonucleotide, which when exposed to UV radiation at 350 nm form 
L and LTg and were immediately used for the mutagenesis assay. The photochemical precursor 
specific for LTg is 7-nitroindole nucleoside, with adjacent 3'-Tg (45). The photochemical 
precursor for L is a model of Norrish I type precursor (48,49). The structures of precursors were 
shown in the scheme 4.3. After the synthesis of precursor containing oligonucleotides, they were 
treated with 3 M NH4OAc and EtOH for purification. Purity of these oligos was checked by 20 % 
PAGE electrophoresis. The purified oligonucleotides were characterized by ESI-MS and their 







             
            
            SCHEME 4.3: Formation of 2-deoxyribonolactone (L) from photochemical precursor,   
            exposed to UV radiation at 350 nm. The precursor was incorporated in the  
            oligonucleotide sequences shown.   
               
  5'-GAAGACCTL*GGCGTCC-3' 









4.2.3 Modified pMS2 vector preparation with site specific incorporation of Tg, L, LTg:  
Single stranded pMS2 plasmid extracted form E.coli, was employed to insert the 16-mer adducts 
containing, Tg, L, and LTg. pMS2 vector contains a restriction site which was digested by EcoRV 
enzyme. A 62-mer scaffold was then annealed to the gapped plasmid. The adducts with Tg, LpTg 
and Lp (p-photochemical precursor for L) were phosphorylated at 5' end using T4 polynucleotide 
kinase. The phosphorylated adducts were then rested on ice for 10 min. To the vials with Lp, LpTg, 
add 0.1 M HEPES buffer (pH 7, final concentration-0.01 M) and exposed to the UV radiation at 
350 nm using a photochemical reactor (Rayonnet) for 20 min at 4 ºC. After 20 min, the vials were 
further cooled on ice for 10 min. To these respective phosphorylated adducts, the pMS2-annealed 
scaffolds were mixed and incubated for ligation at 16 ºC for 2 h using T4 DNA ligase enzyme to 
obtain re-circularized modified vector. Later, the scaffold was removed by T4 DNA polymerase 
by incubating at 16 ºC for 1 h. Immediately after this step, the unreacted oligos, salts and enzymes 
were removed by using Amicon®-100 k MWCO ultracentrifugation columns, which retain the 








4.2.4 Replication of isolated-Tg, isolated-L and tandem-LTg: 
Modified pMS2 vectors with site specifically incorporated Tg, L and LTg were transfected in HEK 
293T cells by transfection using lipofectamine 2000 and opti-MEM reagents. The cells were then 
harvested, DNA was extracted, and the mutants were screened by Southern blot hybridization as 
described in the experimental section. The mutants selected were sent for commercial sequencing 
analysis to obtain the position and the type of mutation in a particular sample. Here, modified 
vectors with isolated Tg, isolated L and tandem LTg were replicated in HEK 293T cells, single 
TLS polymerase knockout cell lines (pol 𝝶, pol 𝝹, pol 𝝸, pol 𝝵). The TLS efficiency and total 


















I. ISOLATED THYMINE GLYCOL (Tg) 
 
4.3.1 Complete mutation profile of isolated lesion Tg, when replicated in HEK 293T cells 
















FIGURE 4.2: Total mutation profile of isolated-Tg lesion, when replicated in HEK 293T cells 
and polymerase knockdown (KD)/knockout (KO) cells. Data obtained from two/three 
independent experiments. *(p < 0.05); **(p < 0.005) 
 
 
Figure 4.2 represents the total mutation profile obtained by analyzing the sequencing data. The 
mutations obtained were categorized into targeted and semi-targeted. Targeted represents the base 
substitutions/deletions opposite lesion bearing site (Tg). Semi-targeted represents base 
substitutions/deletions on the 5' and 3' flanking regions of targeted site (Tg). In 293T cells, about 
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3.4 ± 0.1 % of plasmid progeny recovered were identified as mutants, which include 3.2 ± 0.3 % 
targeted and 0.2 ± 0.01 % semi-targeted mutations. It was observed that the overall mutation 
frequencies increased, when Tg was replicated in all single knockout (KO) cell lines (pol 𝝶, pol 𝝹, 
pol 𝝸, pol 𝝵). Among these, greater increase in mutation frequencies, to 4.9 ± 1.3 % and 4.8 ± 0.6 
% were found in pol 𝝵 KO and pol 𝝹 KO cells respectively. It was obvious that the targeted 
mutations were more prevalent that semi-targeted mutations, except for pol 𝝵 KO where the they 
occur in same proportion. Based on the above observations, it was evident that pol 𝝵 and pol 𝝹 
possesses an important role in the Tg bypass. Hence, to confirm this observation, Tg was further 
replicated in a specific double knockout/knockdown (KO/KD) cell line, with pol 𝝵 KO + pol 𝝹 
KD. We observed that, the mutation frequency was further increased when pol 𝝵 and 𝝹 were 
removed, which is 5.5 ± 0.1 %. This data supports the role of pol 𝝵 and pol 𝝹 in the replicative 
bypass of Tg. It is notable that semi-targeted mutations were observed in 293T, Pol 𝝵 KO and pol 
𝝵/𝝹 KO cells. 
 
4.3.2 Targeted point mutations at isolated-Tg lesion, replicated in HEK 293T cells and TLS 
polymerase knockout cells: 
Figure 4.3 shows the different targeted point mutations of Tg when replicated in various types of 
cell lines. The common types of base substitutions observed in all the experiments were Tg->A 
and Tg->G. Other types include, Tg->C and targeted Tg deletion which were found in 293T, pol 
𝝵 and pol 𝝵/𝝹 KO cells. In WT 293T cells, the occurrence of Tg->A was 0.8 ± 0.1 %, which was 
increased to 3.9 ± 0.1 % in pol 𝝸 KO and reduced to 0.3 ± 0.03 % in pol 𝝵 KO cells. Removal of 
pol 𝝵/𝝹 didn’t affect the occurrence of Tg->A but lowered the Tg deletions from 1.6 ± 0.98 % in 
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WT 293T to 0.65 ± 0.07 %. Significantly, pol 𝝸 plays a role in lowering the proportion of Tg->A 











FIGURE 4.3:  Targeted point mutations at isolated-Tg site, when replicated in HEK 293T and 
TLS polymerase knockout (KO)/knockdown (KD) cells. Data obtained from two/three 
independent experiments. * (p < 0.05); ** (p < 0.005) 
 
 
4.3.3 Role of TLS polymerases in the bypass of Tg: 
Overall, the mutation frequency is very low ~3.4 % in 293T cells, which means that >95 % of the 
progeny was bypassed in an error-free manner by the action of replicative polymerases. It can also 
be inferred that, TLS polymerases 𝝵 and 𝝹 add up to promote the error-free bypass of Tg. From 
these observations, we can propose that pol 𝝹 inserts the base opposite Tg and pol 𝝵 in the extension 





II. ISOLATED 2-DEOXYRIBONOLACTONE (L) 
 
4.3.4 Complete base incorporation profile opposite isolated-L lesion, when replicated in 
HEK 293T cells and TLS polymerase knockout cells: 
As described earlier, mutagenicity and cytotoxicity of L and LTg were determined. Since 2-
deoxyribonolactone is an oxidized abasic site, the sequencing data obtained, specifying the types 
of base insertions/deletions opposite L, were categorized as ‘full length products’ (FLPs) and 
‘deletions’ ((-1)frameshift/ (-2)frameshift mutations). Full length products include, the 















FIGURE 4.4: Percentage progeny recovered including base incorporation (full length products) 
opposite isolated-L and targeted deletions, when replicated in HEK 293T and polymerase 
knockout (KO)/ knockdown (KD) cells. Data obtained from two/three independent experiments. 




Figure 4.4 shows the total mutation profile of isolated 2-deoxyribonolactone with 5' dT flanking 
base (5'-TL). Among the replicated progeny in 293T cells, nearly 86 ± 3.2 % were FLPs and 14 ± 
3.2 % deletions. The percentage of FLPs altered in the TLS polymerase KO cells, reveals that 
bypass of L occurs by TLS mechanism. Significant reduction in the FLPs to 41 ± 3.5 % was 
observed in pol 𝝶 KO cells and 63 ± 1.3 % in pol 𝝵 KO cells. To compensate the FLPs, the deletions 
were increased in the inverse order among KO experiments, which was 59 ± 3.5 % in pol 𝝶 KO 
cells, 37 ± 1.3 % in pol 𝝵 KO cells. Notable change in FLPs and deletions was not observed in pol 
𝝸 and pol 𝝹 deficient cells. Therefore, pol 𝝶 and pol 𝝵 possesses important roles in the replicative 
bypass of isolated L.   
 
4.3.5 Targeted base incorporation opposite isolated-L, in HEK 293T cells and TLS 
polymerase knockout cells: 
Figure 4.5 shows the specific base incorporations (dA, dG, dT, dC) opposite L, included as FLPs, 
in the 5'-TL sequence. It was observed that, replication of L in 293T cells and polymerase-KO 
cells, yielded majority of dA incorporation opposite L, which aligns with the ‘A-rule’ in contrast 
to in E.coli as reported in literature (24). In 293T cells, percentage of dA incorporation was 59 ± 
13 %, which was increased in all the pol-KO cells, ranging from 75%-78 %. In spite of the 
predominant ‘A-rule’, it is notable that, significant dT incorporation opposite L was found as 35 ± 
14 % in 293T cells, which was decreased to 3 %-11 % in KO cells. This shows that the TLS 
polymerases also promote the incorporation of dT at the expense of dA opposite L in WT 293T 



















FIGURE 4.5: Targeted base incorporation opposite isolated-L, when replicated in HEK 293T 
and polymerase knockout (KO)/knockdown (KD) cells. Data obtained from two/three 
independent experiments. * (p < 0.05); ** (p < 0.005) 
 
4.3.6 Role of TLS polymerases in the bypass of 5'-TL: 
From the FLPs and TLS efficiency data in pol-deficient and 293T cells, it was evident that bypass 
of L require TLS polymerases. Especially, pol 𝝶 is required in the identification and insertion of 
nucleobase opposite L to yield FLP, thus reducing the (-1) frameshift mutations. Additionally, pol 
𝝶 also improves the survival of the cells. Although pol 𝝵 doesn’t have a role in the TLS efficiency 
it is important in the generation of FLPs as shown in figure 4.12. Hence, pol 𝝶 can solely insert 






4.3.7 Sequence-dependent bypass of L (5'-TL and 5'-CL): 
To investigate the role of 5' flanking bases in the bypass of L, additionally a modified vector with 
5'-CL adduct was constructed and replicated in 293T cells. The data containing FLPs, deletions 
and targeted base incorporations were obtained from sequencing analysis. The proportion of FLPs 
was decreased to 81 ± 0.6 % in 5'-CL from 86 ± 3.2 % in 5'-TL bypass as shown in figure 4.6. The 
proportion ratio of targeted base incorporations (dA, dG, dT, dC) opposite L remained the same, 
predominantly with dA (65 ± 1.3 %) and dT (19 ± 2.5 %) in 5'-CL bypass represented in figure 
4.7. Therefore, it was evident that the A-rule was still followed even with different 5' nucleobase 
sequence containing L. Hence, it can be deduced that 5'-CL will be replicated with the similar 












FIGURE 4.6: Percentage progeny recovered corresponding to 5'-TL and 5'-CL, including base 
incorporations (full length product) opposite isolated-L and deletions, when replicated in HEK 


















FIGURE 4.7: Targeted base incorporation opposite L, when 5'-TL and 5'-CL were replicated 


























III. TANDEM LESION: 5'-LTg-3' 
 
 
4.3.8 Complete base incorporation profile of tandem lesion, 5'-LTg-3', when replicated in 














FIGURE 4.8: Percentage of progeny recovered corresponding to tandem lesion 5'-LTg-3', 
including base incorporation (full length product) opposite ‘L’ and deletions (1b and 2b), when 
replicated in HEK 293T and polymerase knockout cells. Data obtained from two/three 
independent experiments. * (p < 0.05); ** (p < 0.005) 
 
Complete mutation profile of LTg was categorized into full length products (FLPs), L-deletion (1b 
deletion), L & Tg-deletion (2b deletions), as represented in the figure 4.8. In 293T cells, the 
fraction of FLPs was 83 ± 3.4 %, reduced to 63 ± 0.3 % in pol 𝝵 deficient cells, to 65 % in both 
pol 𝝹 and pol 𝝸 KO cells. Elimination of Pol 𝝶 had no effect on the proportion FLPs. The most 
notable observation was the incidence of 2b-deletions (L & Tg) in only pol 𝝵 and pol 𝝸 KO cells, 
which was 3.2/3.3 ± 0.4 % respectively. Also, the percentage of 1b-deletions (L), increases from 
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17 ± 3.3 % in 293T cells to 34 ± 0.7 % and 32 ± 0.7 % in pol 𝝵 and pol 𝝸 KO cells respectively. 
Hence, it can be deduced that pol 𝝵 and pol 𝝸 play a critical role in the elimination of the frameshift 
mutations in the tandem lesion bypass. 
 
4.3.9 Base incorporation opposite 5'-Targeted (L) component as part of tandem lesion, in 











FIGURE 4.9: Base incorporation opposite 5'-targeted (L) site as part of LTg, when replicated 
in HEK 293T and polymerase knockout cells. Data obtained from two/three independent 
experiments. * (p < 0.05); ** (p < 0.005) 
 
 
From the figure 4.9, dA incorporation opposite 5'-targeted (L) within LTg, in 293T cells was 75 ± 
2.1 %. This was reduced to 65 ± 1.9 % in pol 𝝵 KO, 68 ± 0.1 % in pol 𝝸 KO and increased to 84 ± 
2.3 % in pol 𝝶 KO cells. Therefore, dA incorporation opposite L was predominant in the bypass 
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of tandem lesion, followed by dG and to a small extent of dT and dC. Thus, A-rule is facilitated 
by pol 𝝵 and pol 𝝸 opposite 5'-targeted (L).    
 
4.3.10 Mutation profile of 3'-Targeted (Tg) component as part of tandem lesion in HEK 











FIGURE 4.10: Mutation profile of 3'- Targeted (Tg) component as part of LTg, when replicated 
in HEK 293T and polymerase knockout (KO) cells. Data obtained from two/three independent 




Figure 4.10 represents the total mutation frequencies of 3'-targeted (Tg) as part of LTg replication. 
The data shows that the predominant incorporation is dA, which was >87 % in 293T cells. 
Elimination of pol 𝝹, pol 𝝵 and pol 𝝸 resulted in the increased mutation frequencies to 17 ± 0.1 %, 
16 ± 0.1 %, 29 ± 1.3 % respectively from 10 ± 2.6 % in 293T cells. It was reduced to 4.5 ± 1.5 % 
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in pol 𝝶 KO cells. Despite the different trends, pol 𝝸 was evidently responsible for the error-free 
bypass of Tg within the tandem lesion, followed by pol 𝝹 and pol 𝝵.  
Figure 4.11 represents the 3'-targeted Tg plot with point mutations and deletions obtained from 
different experiments. Notably, Tg deletions were observed only in pol 𝝵 and pol 𝝸 KO cells at 
similar frequencies. Point mutations, Tg->A, Tg->G and Tg->C were found in all the experiments 
and at varied frequencies. However, elimination of pol 𝝸 resulted in the increase of mutation 
frequencies, Tg->A and Tg->G to 16 ± 0.1 % and 13 ± 1.3 % respectively. From these 
observations, it was evident that in case of 3'-targeted (Tg), pol 𝝵 and pol 𝝸 promote the error-free 












FIGURE 4.11: 3' Targeted (Tg) point mutations when 5'-LTg-3' was replicated in HEK 293T 
and TLS polymerase knockout (KO) cells. Data obtained from two/three independent 





4.3.11 Role of TLS polymerases in the bypass of tandem lesion, LTg: 
From the different representations of the data corresponding to the components 5'-L and 3'-Tg 
within the tandem lesion, it can be deduced that LTg replication in 293T cells occur through TLS 
mechanism and that it is a strong replication block.  In this study, it was evident that pol 𝝵 and pol 
𝝸 take over the responsibility of efficient bypass of the components, 5'-L & 3'-Tg in tandem, that 
is by incorporation dA opposite both the lesion sites. This was demonstrated by the corresponding 
single knockout experiments, which increased the (-2) frameshift mutations in 5'-L and mutation 
frequencies in 3'-Tg. 
 











FIGURE 4.12: TLS efficiencies of Tg, LTg and L in HEK 293T and polymerase knockout (KO) 





Figure 4.12 shows the TLS efficiencies of the three adducts, isolated Tg, tandem lesion 5'-LTg-3' 
and isolated lesion 5'-TL in the respective order. Firstly, TLS efficiency in the bypass of Tg was 
discussed, followed by L and then 5'-LTg-3'. 
TLS efficiency of Tg was reduced in pol-KO cells compared to ~95 % in 293T cells, which shows 
that Tg is not a strong replication block. Removal of Pol 𝝵 resulted in maximum reduction in TLS 
efficiency ~40 %, followed by 20 % in Pol 𝝸 KO, 10 % in pol 𝝹 KO and 6 % in pol 𝝶 KO cells. 
Hence, it was evident that pol 𝝵 has an important role in the bypass of Tg with higher survivability. 
Secondly, the TLS bypass efficiencies of L in the form of two sequence dependent adducts, 5'-TL 
and 5'-CL was discussed. TLS efficiency of 5'-TL in 293T cells was 19 ± 0.6 %, which was reduced 
to 15 ± 2.1% in pol 𝝶 KO cells. TLS efficiency was not affected when pol 𝝸 and pol 𝝵 was 
eliminated. However, it was increased to 32 ± 2.1 % in pol 𝝹-deficient cells. Based on these 
variations in TLS efficiencies of polymerase deficient cells, it can be assumed that, pol 𝝶 possess 
an important role in the replicative bypass of L and that recruitment of pol 𝝹 blocks the replication. 
In comparison, 5'-CL replication reduced the cell survival ~4-fold in 293T cells, i.e., 5.5 ± 0.3 %. 
It can be hypothesized that 5'-flanking sequence distorted the DNA in a way that the TLS efficiency 
was compromised, hence reducing the survivability. 
 Lastly, TLS efficiency of tandem lesion, LTg in 293T cells was 6 ± 0.2 %, it drastically increased 
~5-fold in pol 𝝹 deficient cells. There exist fluctuations in the TLS efficiencies in other pol-
deficient cells, ranging from 4-12 %. Hence, similar to isolated L, recruitment of pol 𝝹 might result 
in the formation of unproductive replication complexes which block the replication of tandem 













FIGURE 4.13: TLS efficiencies of 5'-TL and 5'-CL in HEK 293T cells. Data obtained from 

















Oxidized abasic lesions form an important class of DNA damages, when left unrepaired can be 
bypassed by TLS mechanism. In this study, we investigated the TLS bypass of one such tandem 
lesion with two components, 5'-L and 3'-Tg, along with isolated lesions L and Tg in HEK 293T 
cells. We have generated three single stranded plasmids with site specific incorporation of isolated 
L, isolated Tg, tandem LTg adducts and replicated in HEK 293T cells. Earlier studies revealed that 
isolated lesion Tg was a strong replication block and also weakly mutagenic (< 1 %) in E.coli 
(10,13). It was also reported that the mutagenicity of Tg increases in E.coli when it is a part of 
tandem lesion (5). Earlier studies on the TLS bypass of isolated Tg located on both leading and 
lagging strands of the DNA by Prakash and colleagues (13) in human cells revealed that, pol 𝝹 and 
pol 𝝵 act together to bypass Tg, that the former inserts the correct nucleotide opposite Tg (non-
mutagenic) and the latter extends in an incorrect manner beyond the lesion (mutagenic) (13). In 
this research on the TLS bypass in human cells, the isolated Tg was found mutagenic and it 
increased when it was a part of tandem lesion as 3'-Tg. It also aligns with the previous study, that 
the TLS polymerases necessary for the isolated Tg bypass were pol 𝝹 and pol 𝝵, as proved by the 
increased mutagenicity of Tg in double knockout pol 𝝹/𝝵 experiment. Further, the TLS bypass of 
LTg in HEK 293T cells and the mutagenicity of 3'-Tg and 5'-L were analyzed together and 
separately, which showed that pol 𝝵 and pol 𝝸 was responsible for efficient bypass. The higher 
percentage of dG incorporated opposite 3'-Tg in WT 293T cells can be explained due to the error-
prone nature pol 𝝸. Further, pol 𝝵 and pol 𝝸 play an important role in the elimination of (-2) 
frameshift mutations (deletion of L & Tg) in the replication of tandem lesion. Hence, the isolated 
Tg and tandem LTg containing adducts were efficiently replicated by different TLS polymerases, 
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with pol 𝝵 being the common one and it can be speculated that it participates in the extension step 
of TLS.  
Previous studies on isolated 2-deoxyribonolactone (L) showed that it was bypassed in E.coli 
(19,24,50), S. cerevisiae (21) and human cells (51). In E.coli, the survival of the cells with L, 
depends on competitive bypass by SOS pol V, result in deletions and dG/dA substitutions. On the 
other hand, Pol II/ pol IV, play a role in the replication past the lesion and also in the elimination 
of - 1 frameshift mutations (deletions) (24,50). The incidence of deletions was particularly 
observed with respect to the local sequence 5' to L, that is 5'-TL and 5'-CL. Deletions were only 
observed in 5'-CL (24). In this study, we have explored the similar effect of the local sequence, 5'-
TL and 5'-CL in HEK 293T cells, where deletions were observed in both adducts. However, 
targeted deletions increased in 5'-CL compared to 5'-TL adduct. The overall proportion of FLP to 
the targeted deletions remained the same when both the adducts were replicated in 293T cells. 
Moreover, the TLS efficiency differed significantly in 5'-CL which dropped to ~27 % compared 
to 5'-TL. The dominant base incorporations were dA, followed by dT for both sequence types. The 
base incorporations opposite L were not influenced by the 5'-local nucleobase which was similar 
to E.coli, as reported in (50). Taking this into consideration, the TLS bypass and the corresponding 
base incorporations was studied for a single model of 2-deoxyribonolactone, 5'-TL in 293T cells.   
In 5'-TL adduct, the major polymerases which were found to play a role in the TLS were pol 𝝶 and 
pol 𝝵.  This was evident from the pol 𝝶 KO and pol 𝝵 KO experiments, where the occurrence of (- 
1) frameshift mutations increased by 4-fold and 2.5-fold respectively. It was also noted that all the 
TLS polymerases promote the incorporation of dA, following ‘A-rule’, along with significant dT 
incorporation opposite L. Similarly, TLS mechanism followed ‘A-rule’ with respect to 5'-L 
component within tandem lesion, but dT incorporation was very less. In vitro studies of isolated L 
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and tandem LTg bypass using X-family DNA polymerases revealed that, pol 𝝱 alone can bypass 
isolated L by dA incorporation and that it was strongly blocked by the tandem lesion, LTg. It was 
also speculated that B-family polymerase, pol 𝝵 aid in its extension (51). Another tandem lesion 
bypass with different components, 5'-8oxodG, Tg-3' was reported in E.coli, which reported that 
the overall mutagenicity was increased and TLS efficiency was reduced by half (52).  To our best 
knowledge, there was no study reported on the role of B and Y-family polymerases and its 
efficiency, in the bypass of oxidized abasic lesion, in tandem with thymine glycol, 5'-LTg-3' in 
HEK 293T cells, which we report here for the first time using site specific mutagenesis approach.  
We observed that the TLS efficiency of tandem lesion was dropped ~3-fold compared to isolated 
L and ~15-fold to isolated Tg in WT 293T cells.  It was also noted that (-2) frameshift mutations 
were eliminated by either pol 𝝸 or pol 𝝵. The major polymerase responsible for the bypass is 
extension by pol 𝝵, in all the three lesions investigated here. Pol 𝝵 incorporates dA opposite abasic 
site and was necessary in the bypass similar to E.coli, as reported in (53). Significantly, pol 𝝸 was 
necessary in the error-free bypass of 3'-Tg within tandem lesion. It is also worth mentioning the 
unique role of pol 𝝹 in the bypass of isolated L and LTg, where its absence, increased the TLS 
efficiency. Possibly, pol 𝝹 generates unproductive replicative complexes which may blok the 
replication. Pol 𝝶 also has an important role in the tandem bypass which is an analogue of SOS 
pol V in E.coli.  These results indicate that TLS polymerases are essential in the bypass of tandem 







Oxidized abasic sites formed by the hydroxyl radicals are considered as important class of DNA 
damages. They can be efficiently repaired by long-patch BER and NER. If left unrepaired, the 
lesions were replicated by TLS. Tandem lesions, a part of clustered lesions is mutagenic as well 
as cytotoxic in humans. In this study, we explored the TLS bypass of isolated Tg, isolated L and 
tandem LTg. Here, we summarize our findings as isolated Tg was not a strong block of replication 
in human cells and was weakly mutagenic. But the mutagenicity of Tg increased when it is part of 
tandem lesion. TLS bypass of Tg was achieved by pol 𝝹 and pol 𝝵 (54). Isolated L was found to 
be a stronger block of the replication and that pol 𝝶 & 𝝵 were necessary. Further, the tandem lesion, 
LTg which was reported to occur more frequently in the cells, was a very strong block of DNA 
replication. The smaller proportion of recovered progeny from the tandem lesion bypass, was aided 
by pol 𝝸 and pol 𝝵 for both components 5'-L & 3'-Tg. The roles of TLS polymerase altered when 
the adducts were replicated singularly vs in tandem. Hence, tandem lesions formed as a result of 
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Translesion synthesis bypass of Fapy.dG lesion (N-2, 6-diamino-4- 


















Oxidative stress in the cells generates a plethora of DNA lesions from the modified 
purines/pyrimidines and backbone sugar moieties (1-4). Various lesions include formation of DNA 
protein cross-links, tandem lesions, abasic sites and strand breaks (4). If left unrepaired, these 
damages can result in oxidative induced damage is caused by the exposure of DNA to oxidizing 
agents, which generates ROS. One such common highly reactive ROS is hydroxyl (OH•) radical 
(1, 2, 5). OH• add to the double bonds of purines at C8 position to generate N7-radicals, which 
upon further reactions produce 8-oxopurines and formamidopyrimidines (Fapy) (6-9). Of these, 
dG is more susceptible to oxidation because of their lower reduction potential (10). Therefore, 
formation of 8-oxo-7, 8-dihydro-2'-deoxyguanosine (8-oxo.dG),  N-(2-deoxy-D- pentofuranosyl)-
N-2, 6-diamino-4-hydroxy-5-formamidopyrimidine) (Fapy.dG) are more prevalent. The relative 
proportions of 8-oxo.dG to Fapy.dG depends on the oxidative conditions at the time of lesion 
formation (11, 12). The common N7-radical intermediate undergo one-electron oxidation to form 
8-oxo-dG and other direction is to undergo 𝝱-fragmentation followed by reduction to form 
Fapy.dG (2, 13, 14).  For example, when DNA is exposed to 𝝲-radiolysis, greater proportion of 8-
oxo.dG is formed under aerobic conditions and Fapy.dG under anoxic conditions (7, 13). Whereas, 
exposure of human leukemia cells to ionizing radiation forms Fapy.dG,  ~3-fold higher than 8-
oxo.dG (13, 15, 16). Both are observed in comparable amounts, when DNA is irradiated with UV 





















SCHEME 5.1: Formation of 8-oxo.dG and Fapy.dG from oxidation of deoxyguanine by a 
hydroxyl radical. The N7 radical intermediate formed undergo either one electron oxidation to 
form 8-oxo.dG or one electron reduction to form Fapy.dG 
 
Extensive studies on the mutagenesis of 8-oxo.dG were done previously and Fapy.dG to some 
extent in E.coli (15),mammalian (18) and human (19) cells. SOS induction in E.coli increases the 
bypass efficiency of 8-oxo.dG, but has no effect in the Fapy.dG (15). Moreover, Fapy.dG is found 
to be weakly mutagenic in E.coli (15) in contrast to its bypass in mammalian COS-7 cells (18). It 
was also reported that Fapy.dG is ~25 % more mutagenic than 8-oxo.dG in COS-7 cells (18). A 
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study on the mutagenicity of both dA and dG derived adducts of 8-oxopurines and 
formamidopyrimidines was conducted by Kalam and colleagues (18), where it was reported that 
dA-derived adducts are weakly mutagenic than its corresponding dG adducts. It was also reported 
that, Fapy.dG is a potent mutagenic lesion and 8-oxo.dA is a weak one in COS-7 cells. In vitro 
TLS studies proved that 8-oxo.dG is bypassed in an error-free manner by X-family polymerase 𝝺 
with correct dC incorporation opposite the damaged base. It was rather proved in HEK 293T cells, 
that error-free bypass of 8-oxo.dG (20, 21) and error-prone bypass of Fapy.dG was facilitated by 
pol 𝝺 in different sequence contexts (19). Hence, Pol 𝝺 is also responsible for the induction of      
G–>T transversions in the replication of Fapy.dG. However, the influence of B and Y family TLS 
polymerases in HEK 293T cells is not yet explored, which is primary focus of this study.  
Fapy.dG adduct exists as both syn- and anti- conformations around the glycosidic bond which 
influences the complementary base pair interaction. It also exists in 𝝰- and 𝝱- anomeric forms, 
which are interconvertible and influence the cytotoxicity (22-26). Earlier thermodynamic studies 
(23) on the anomeric influence in the replication of Fapy.dG showed that, 𝝰 anomer destabilizes 
the double helix and thus strongly blocks the replication in vitro. This is assumed to be because of 
the position of the lesion outside the helix and hence is cytotoxic. However, 𝝱 anomer also blocks 
the DNA replication in vitro to a lesser extent and is found to predominant in DNA (13, 22, 23). 
Studies performed in human cells revealed that the mutagenicity is clearly obtained from the 
predominant 𝝱- anomeric form of Fapy.dG adduct (13). On the other hand, it is also influenced by 
the syn- and anti-conformations adapted by the adduct (27). It was reported that 8-oxo.dG exists 
in the energy-driven syn- conformation which leads to G->T mutations and anti- in the non-
mutagenic bypass. In contrast to this, the energy-favorable conformation of Fapy.dG is anti- which 
incorporates dC opposite to it (4, 15, 27, 28). Fapy.dG also exists in the syn- conformation which 
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is responsible for the occurrence of G->T mutations (4, 15, 27). Overall, Fapy.dG is considered to 
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 121 
5.2 Repair:  
Formamidopyrimidines and 8-oxopurines are efficiently repaired by BER mechanism as reviewed 
in (4) and (13), where various DNA glycosylases participates in the excision of the damaged bases 
(29-31). In E.coli, three DNA glycosylases participate in the repair of oxidative DNA lesions, 
namely, endonuclease III (Nth), endonuclease VII (Nei) and formamidopyrimidine DNA 
glycosylase (fpg), whose analogues found in humans as hNTH1, hNEIL and hOgg1 respectively 
(30, 32). Fpg efficiently excise 8-oxodG, Fapy.dG and Fapy.dA at similar kinetic rates (8) but with 
different recognition criteria (28) was reported in vitro by Widerholt and colleagues (33). But 
hOgg1 can repair only 8-oxo.dG and Fapy.dG, not Fapy.dA (34, 35). It was reported that both the 
enzymes efficiently repairs the Fapy.dG:dC substrate than Fapy.dG:dA mispair and that the latter 
was repaired by MutY/MutYH enzyme, a part of enzyme cluster called ‘GO system’ similar to the 
8-oxo.dG (36). MutY/MutYH enzyme removes the complementary nucleotide dA from the 
mispair, hence is unable to repair the FapydA:dA substrate (33, 37). It was reported that the latter 
was repaired by glycosylases Nei, (E.coli) (38) & NEIL (humans) (39). hNEIL family includes 
three enzymes (NEIL1, NEIL2, NEIL3) specific for different lesions (32). In this case, NEIL1 is 
involved in the repair of wide variety of oxidative purines/pyrimidines including Fapy.dA because 
of its broader specificity (40). hOgg1 specifically repair the adducts on the double strand DNA 
and hNEIL1 acts on the single stranded DNA forks or bubble structures that form during DNA 
replication and transcription (39, 41). In the DNA with multiple lesions, enzymes Nth and Nei can 
efficiently excise only Fapy.dA in E.coli (38). Whereas in humans, hNEIL1 alone excise both 




5.3 Fapy.dG adduct:  
Fapy.dG was prepared using a novel synthetic approach by Greenberg and colleagues 
(unpublished) and was site specifically incorporated in a 12-mer oligonucleotide. The 12-mer 
employed in this study represents a part of p53 gene sequence and the lesion site was located at a 
273 codon (CG*T). The resulting adduct was analyzed by mass spectrometry. The structure and 























5.4.1 Replication of Fapy.dG in human cells: 
Single stranded pMS2 vector with inserted 12-mer adduct containing Fapy.dG was constructed 
and quantified using agarose gel electrophoresis. This vector was replicated in HEK 293T cells 
along with TLS-polymerase knockout/knockdown cells and were collected. The DNA was 
harvested, replicated in E.coli DH10B cells and the mutants were screened by Southern blot 
hybridization. These selected progeny were commercially sequenced to determine the type and the 
position of the mutation in the adduct. The sequence of the Fapy.dG is shown below, 
 
     5' – GTGCG*TGTTTGT - 3' 














5.4.2 TLS efficiency: 
Figure 5.3 shows the TLS efficiencies of Fapy.dG in HEK 293T cells and various single 
polymerase knockout (KO) cells (pol 𝝶, pol 𝝸, pol 𝝹, pol 𝝵). The TLS efficiency in 293T cells was 
72 ± 1.4 %, was reduced to 29 ± 3.5 % in pol 𝝹 KO cells, 47 ± 4.9 % in pol 𝝶 KO cells and 53 ± 
0.7 % in pol 𝝵 KO cells. TLS efficiency of Fapy.dG was not affected when pol 𝝸 was eliminated. 
From these values, it was evident that pol 𝝹 play an important role in the bypass of Fapy.dG and 















FIGURE 5.3: TLS efficiency of Fapy.dG in HEK 293T cells along with four single polymerase 













5.4.3 Complete mutation profile of Fapy.dG in HEK 293T and polymerase-deficient cells: 
The mutational data obtained after the sequencing was categorized into targeted and off-targeted 
mutations as shown in the figure 5.4. Targeted mutations represent the point base 
mutations/deletions at the lesion site and off-targeted mutations represent the base 
substitutions/deletions on the 5' and 3' flanking regions of the adduct. In 293T cells, mutation 
frequencies (MF) correspond to targeted mutations was 10.3 ± 0.4 %, reduced to 3.6 % in pol 𝝵 
KO cells, 4.8 ± 0.2 % in pol 𝝸 KO cells and 6.4 ± 0.3 % in pol 𝝹 KO cells. Off-targeted mutations 
in HEK 293T cells was 0.6 ± 0.4 %, increased to 1.1 ± 0.1 % in pol 𝝸 KO cells. No change in the 
MF was observed in pol 𝝵 KO cells and they were eliminated in pol 𝝹 KO cells. From these 
observations, it can be deduced that pol 𝝵, pol 𝝸 and pol 𝝹 may play a critical role in the error-prone 




















FIGURE 5.4: Mutation frequencies correspond to targeted and off-targeted mutations, when 
Fapy.dG was replicated in HEK 293T cells and single polymerase-knockout cells. Data 
represent three independent experiments.  
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5.4.4 Mutation frequencies of targeted point mutations at Fapy.dG lesion site, when 
replicated in HEK 293T and polymerase-deficient cells:  
Among the targeted mutations, base substitutions were prevalent than deletions as represented in 
the figure. Of the targeted base substitutions, G->T transversions possesses greater MF in 293T 
cells, that is 7.4 ± 0.1 % of G -> T, 1.5 ± 0.1 % of G -> C, 0.9 ± 0.1 % G -> A. The incidence of 
significant proportion of all these targeted substitutions were observed in pol 𝝵, pol 𝝸 and pol 𝝹 
cells. Proportion of G->T transversions was 2 % in pol 𝝵 KO cells, 3.1 ± 0.1 % in pol 𝝹 KO cells 
and 3.3 % in pol 𝝸 KO cells. These were found to be relative to other base substitutions in these 
cells. From the data (figure 5.5), it can be deduced that pol 𝝵, pol 𝝸 and pol 𝝹 play a role in the 
error-prone bypass and can be assumed that Fapy.dG adapts syn- conformation when it was 


















FIGURE 5.5: Targeted point mutations at Fapy.dG site, when replicated in HEK 293T and 







From the data obtained from WT 293T and single polymerase-knockout (pol 𝝶, pol 𝝸, pol 𝝹, pol 
𝝵) experiments, it can be hypothesized that pol 𝝸, pol 𝝹, pol 𝝵 act synergistically in the bypass of 
Fapy.dG in an error-prone manner. It is also notable that pol 𝝶 didn’t affect the bypass in a 
significant way. In addition to this, Fapy.dG tend to adapt both syn- and anti- confirmations in 
human cells. As reported in the literature (26, 28), the energy-favorable anti-conformation of 
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